<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-43817</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0092447</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological tissue</subject><subj-group><subject>Muscle tissue</subject><subj-group><subject>Muscle cells</subject></subj-group></subj-group></subj-group><subj-group><subject>Musculoskeletal system</subject><subj-group><subject>Muscles</subject></subj-group></subj-group></subj-group><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subject>RNA</subject></subj-group></subj-group><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subject>Molecular cell biology</subject></subj-group></subj-group><subj-group><subject>Computational biology</subject></subj-group><subj-group><subject>Developmental biology</subject><subj-group><subject>Cell differentiation</subject></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject></subj-group></subj-group><subj-group><subject>Physiology</subject><subj-group><subject>Muscle physiology</subject><subj-group><subject>Muscle biochemistry</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Identification of Genes Differentially Expressed in <italic>Myogenin</italic> Knock-Down Bovine Muscle Satellite Cells during Differentiation through RNA Sequencing Analysis</article-title>
<alt-title alt-title-type="running-head">RNA-seq Analysis of MyoG Knock-Down in Bovine MSCs</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>Eun Ju</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Malik</surname><given-names>Adeel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pokharel</surname><given-names>Smritee</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmad</surname><given-names>Sarafraz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mir</surname><given-names>Bilal Ahmad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cho</surname><given-names>Kyung Hyun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>Jihoe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kong</surname><given-names>Joon Chan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>Dong-Mok</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chung</surname><given-names>Ki Yong</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>Sang Hoon</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Choi</surname><given-names>Inho</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>School of Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Bovine Genome Resources Bank, Yeungnam University, Gyeongsan, Republic of Korea</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon-si, Republic of Korea</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Hanwoo Experiment Station, National Institute of Animal Science, RDA, Pyeongchang, Republic of Korea</addr-line></aff>
<aff id="aff5"><label>5</label><addr-line>Department of Biology, Kyung Hee University, Seoul, Republic of Korea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Rota</surname><given-names>Rossella</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Ospedale Pediatrico Bambino Gesù, Italy</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">inhochoi@ynu.ac.kr</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: IC EJL AM. Performed the experiments: EJL AM. Analyzed the data: EJL AM IC SP SA BAM. Contributed reagents/materials/analysis tools: KHC JK JCK DML KYC SHK. Wrote the paper: IC EJL AM SP.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>19</day><month>3</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>3</issue>
<elocation-id>e92447</elocation-id>
<history>
<date date-type="received"><day>28</day><month>10</month><year>2013</year></date>
<date date-type="accepted"><day>21</day><month>2</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Lee et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>The expression of myogenic regulatory factors (MRFs) consisting of <italic>MyoD</italic>, <italic>Myf5</italic>, <italic>myogenin</italic> (<italic>MyoG</italic>) and <italic>MRF4</italic> characterizes various phases of skeletal muscle development including myoblast proliferation, cell-cycle exit, cell fusion and the maturation of myotubes to form myofibers. Although it is well known that the function of <italic>MyoG</italic> cannot be compensated for other MRFs, the molecular mechanism by which <italic>MyoG</italic> controls muscle cell differentiation is still unclear. Therefore, in this study, RNA-Seq technology was applied to profile changes in gene expression in response to <italic>MyoG</italic> knock-down (MyoG<sub>kd</sub>) in primary bovine muscle satellite cells (MSCs).</p>
</sec><sec>
<title>Results</title>
<p>About 61–64% of the reads of over 42 million total reads were mapped to more than 13,000 genes in the reference bovine genome. RNA-Seq analysis identified 8,469 unique genes that were differentially expressed in MyoG<sub>kd</sub>. Among these genes, 230 were up-regulated and 224 were down-regulated by at least four-fold. DAVID Functional Annotation Cluster (FAC) and pathway analysis of all up- and down-regulated genes identified overrepresentation for cell cycle and division, DNA replication, mitosis, organelle lumen, nucleoplasm and cytosol, phosphate metabolic process, phosphoprotein phosphatase activity, cytoskeleton and cell morphogenesis, signifying the functional implication of these processes and pathways during skeletal muscle development. The RNA-Seq data was validated by real time RT-PCR analysis for eight out of ten genes as well as five marker genes investigated.</p>
</sec><sec>
<title>Conclusions</title>
<p>This study is the first RNA-Seq based gene expression analysis of MyoG<sub>kd</sub> undertaken in primary bovine MSCs. Computational analysis of the differentially expressed genes has identified the significance of genes such as <italic>SAP30-like</italic> (<italic>SAP30L</italic>), <italic>Protein lyl-1</italic> (<italic>LYL1</italic>), various matrix metalloproteinases, and several glycogenes in myogenesis. The results of the present study widen our knowledge of the molecular basis of skeletal muscle development and reveal the vital regulatory role of <italic>MyoG</italic> in retaining muscle cell differentiation.</p>
</sec></abstract>
<funding-group><funding-statement>This work was supported by a grant from the BioGreen 21 Program (Project no. PJ907099), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="14"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Skeletal muscle formation is a multi-step process that requires proliferation of myocytes, expression of muscle-specific myogenic regulatory factors (MRFs) including <italic>MyoD</italic>, <italic>Myf5</italic>, <italic>myogenin</italic> (<italic>MyoG</italic>) and <italic>MRF4</italic> (or <italic>Myf6</italic>), cell cycle withdrawal, myotube formation by the fusion of mononucleated cells and maturation of myotubes into myofibers <xref ref-type="bibr" rid="pone.0092447-Olson1">[1]</xref>, <xref ref-type="bibr" rid="pone.0092447-Mohun1">[2]</xref>, <xref ref-type="bibr" rid="pone.0092447-Andrs1">[3]</xref>, <xref ref-type="bibr" rid="pone.0092447-Moran1">[4]</xref>, <xref ref-type="bibr" rid="pone.0092447-Janot1">[5]</xref>. MRFs are basic helix-loop-helix (bHLH) transcription factors <xref ref-type="bibr" rid="pone.0092447-Rudnicki1">[6]</xref> that cooperate with several transcription factors of the <italic>myocytes enhancer factor-2</italic> (<italic>MEF2</italic>) family <xref ref-type="bibr" rid="pone.0092447-Naya1">[7]</xref> to regulate myogenesis. bHLH proteins also heterodimerize with E-proteins <xref ref-type="bibr" rid="pone.0092447-Lassar1">[8]</xref>, enabling binding to the E-Box consensus sequence (CANNTG) present in the regulatory regions of muscle specific genes <xref ref-type="bibr" rid="pone.0092447-Murre1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092447-Berkes1">[10]</xref>. Among these MRFs, <italic>MyoD</italic> is highly expressed during the mid-G1 phase and between the S and M phases of the cell cycle, but absent during the G0 phase <xref ref-type="bibr" rid="pone.0092447-Mastroyiannopoulos1">[11]</xref>, whereas <italic>Myf5</italic> is highly expressed during the G0 phase and decreases during the G1 phase <xref ref-type="bibr" rid="pone.0092447-Kitzmann1">[12]</xref>. <italic>MyoG</italic> and <italic>MRF4</italic> (<italic>Myf6</italic>) are expressed upon differentiation of myoblasts into multinucleated myotubes <xref ref-type="bibr" rid="pone.0092447-Molkentin1">[13]</xref>, <xref ref-type="bibr" rid="pone.0092447-Rhodes1">[14]</xref>, <xref ref-type="bibr" rid="pone.0092447-Wright1">[15]</xref>.</p>
<p><italic>MyoG</italic> is crucial during differentiation <xref ref-type="bibr" rid="pone.0092447-Mastroyiannopoulos1">[11]</xref>, as many studies have revealed that mice lacking <italic>MyoG</italic> continue to identify the muscle lineage through the formation of myoblasts <xref ref-type="bibr" rid="pone.0092447-Singh1">[16]</xref>, but show high perinatal mortality due to severe skeletal muscle deficiency caused by disruption of myoblast differentiation and muscle fiber formation <xref ref-type="bibr" rid="pone.0092447-Hasty1">[17]</xref>, <xref ref-type="bibr" rid="pone.0092447-Nabeshima1">[18]</xref>. Additionally, <italic>MyoG</italic>/<italic>MyoD</italic> and <italic>MyoG</italic>/<italic>Myf5</italic> double knockout mice studies have shown that these mice specify the muscle lineage, but the formation of muscle fibers is disrupted, which is similar to <italic>MyoG</italic> knockout mice <xref ref-type="bibr" rid="pone.0092447-Rawls1">[19]</xref>. Furthermore, <italic>MyoD</italic> and <italic>Myf5</italic> are unable to compensate for the role of <italic>MyoG</italic> in differentiation <xref ref-type="bibr" rid="pone.0092447-Myer1">[20]</xref>, and mice that lack <italic>MyoG</italic> exhibit normal expression levels of <italic>MyoD</italic> and <italic>Myf5</italic> <xref ref-type="bibr" rid="pone.0092447-Hasty1">[17]</xref>. This is because <italic>MyoG</italic> acts downstream of <italic>MyoD</italic> and <italic>Myf5</italic> <xref ref-type="bibr" rid="pone.0092447-Singh1">[16]</xref> in skeletal muscle differentiation. Knockout mice studies have also shown a relationship between different MRFs in which the absence of one will be compensated for by another <xref ref-type="bibr" rid="pone.0092447-Rudnicki2">[21]</xref>, <xref ref-type="bibr" rid="pone.0092447-Zhang1">[22]</xref>. The only exception to this compensation effect of MRFs is <italic>MyoG</italic>, which plays a unique and non-redundant role during embryogenesis <xref ref-type="bibr" rid="pone.0092447-Rawls1">[19]</xref>, whereas conditional knock-out resulted in reduced muscle mass in adults <xref ref-type="bibr" rid="pone.0092447-Meadows1">[23]</xref>.</p>
<p>In this study, we conducted a comprehensive transcriptome analysis of primary bovine cells using MyoG<sub>kd</sub> and compared the expression profiles with those of the wild type using an RNA-Seq technique. We also showed that MyoG<sub>kd</sub> led to upregulation of genes involved in processes such as cell proliferation and DNA replication, whereas the genes involved in phosphate metabolic processes were down-regulated. Finally, potential involvement of various new genes in myogenesis was identified.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Bovine MSCs culture</title>
<p>Bovine muscle was collected from the hind leg skeletal muscle of 24–26 month old cattle with a body weight of 550–600 kg. The animals were handled according to a protocol approved by the Animal Care and Concern Committee of the National Institute of Animal Science, Korea. Briefly, the collected muscle was minced into fine pieces, and digested with trypsin-EDTA (GIBCO, CA, USA), and were centrifuged at 90×g for 3 min and the upper phase was passed through a 40-μm cell strainer. The filtrate was centrifuged at 2,500 rpm, pellet was collected, washed twice and cultured in Dulbecco's modified Eagle's medium (DMEM; HyClone Laboratories, UT, USA) supplemented with 10% fetal bovine serum (FBS, HyClone Laboratories) and 1% penicillin/streptomycin at 37°C under 5% CO<sub>2</sub>. The culture medium was changed every other day. To induce differentiation, cells were allowed to grow in DMEM without reducing serum (DMEM with 10% FBS and 1% P/S) for 10, 12, 14, 16, and 18 days. MSCs isolation and culture were conducted as previously described <xref ref-type="bibr" rid="pone.0092447-Lee1">[24]</xref>.</p>
</sec><sec id="s2b">
<title><italic>MyoG</italic> shRNA construction and knock-down</title>
<p>Bovine <italic>MyoG</italic> shRNA was designed using nucleotide information obtained from NCBI (AB257560.1) and cloned with pRNAT-U6.2/Lenti vector (GeneScript, NJ, USA). Constructed <italic>MyoG</italic> shRNA or non-specific sequences (scrambled vector, MyoG<sub>wd</sub>) were transfected to generate viral particles in 293 FT cells. After two days of transfection, the supernatant containing viral particles was collected, transduced with lentiviral particles expressing shRNAs against bovine <italic>MyoG</italic> or scrambled vector in MSCs (Day 8), and selected with 50 μg/ml of G418 (CABIOCHEM, CA, USA). The selected cells were allowed to differentiate and were harvested at Day 21. The following oligonucleotide was used to generate <italic>MyoG</italic> shRNA: sense: <named-content content-type="gene" xlink:type="simple">5′- GGATCCCGCGCAGACTCAAGCCGCCGGTGTTCAAGAGACACCTTCTTGAGTCTGCGCTTTTCCAACTCHGAG-3′</named-content>.</p>
</sec><sec id="s2c">
<title>RNA extraction, library preparation and sequencing</title>
<p>MSCs were allowed to grow till day 10, and were transduced with either scrambled vector or <italic>MyoG</italic> shRNA. Cells were then allowed to grow for another 11 days, and were harvested with Trizol reagent (Invitrogen) according to the manufacturer's protocol. Total RNA was then extracted and stored in diethylpyrocarbonate-treated H<sub>2</sub>O at −80°C until used. The mRNA in total RNA was converted into a library of template molecules suitable for subsequent cluster generation using the reagents provided in the Illumina TruSeq RNA Sample Preparation Kit (Illumina, CA, USA) according to the manufacturer's instructions. Library construction and high-throughput sequencing were carried out using an Illumina HiSeq2000 sequencing system in which each sequencing cycle takes place in the presence of all four nucleotides, leading to higher precision than methods in which only a single nucleotide is present in the reaction mixture at one time. The cycle is repeated one base at a time, creating a string of images each indicating a single base extension at a specific cluster.</p>
</sec><sec id="s2d">
<title>Sequence quality check</title>
<p>The FASTQC [<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/" xlink:type="simple">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>] tool embedded in the web-based platform, Galaxy <xref ref-type="bibr" rid="pone.0092447-Giardine1">[25]</xref>, <xref ref-type="bibr" rid="pone.0092447-Blankenberg1">[26]</xref>, <xref ref-type="bibr" rid="pone.0092447-Goecks1">[27]</xref>, was used to calculate quality control statistics describing raw sequence data from FASTQ files generated by the Illumina second generation sequencing technology (“Solexa”) [<ext-link ext-link-type="uri" xlink:href="http://www.illumina.com/technology/solexa_technology.ilmn" xlink:type="simple">http://www.illumina.com/technology/solexa_technology.ilmn</ext-link>].</p>
</sec><sec id="s2e">
<title>Mapping of RNA-Seq reads transcript assembly</title>
<p>TopHat <xref ref-type="bibr" rid="pone.0092447-Trapnell1">[28]</xref> was used to align RNA-Seq reads against UCSC <italic>Bos taurus</italic> reference genome (Btau_4.6.1/bosTau7) via Bowtie, which is a very high-throughput short read aligner <xref ref-type="bibr" rid="pone.0092447-Langmead1">[29]</xref>. Bowtie is different from other general-purpose alignment tools such as BLAST <xref ref-type="bibr" rid="pone.0092447-Altschul1">[30]</xref>, and shows best performance when short reads are aligned to large genomes. Bowtie is extremely fast for short reads where several reads have at least one significantly valid alignment, the reads are of high-quality, and the number of alignments reported per read is nearly 1 <xref ref-type="bibr" rid="pone.0092447-Langmead1">[29]</xref>. These mapping results were then analyzed to identify splice junctions between exons. All default parameters were used to run TopHat except the mate inner distance, for which a value of 100 was selected in the case of paired reads. The advantage of a paired end run is that both reads contain long range positional information, allowing for highly precise alignment of reads.</p>
<p>The aligned reads were further analyzed by Cufflinks <xref ref-type="bibr" rid="pone.0092447-Trapnell2">[31]</xref> using a multifasta file (bosTau7. fa) option that can improve the precision of transcript abundance approximation by bias detection and a correction algorithm. The relative abundance of transcripts was reported as fragments per kilobase of exon per million fragments mapped (FPKM). An additional cufflinks parameter for the initial estimation procedure was used so that the reads mapping to multiple locations in the genome were accurately weighted <xref ref-type="bibr" rid="pone.0092447-Trapnell2">[31]</xref>. The nucleotide sequences obtained in this study have been submitted and will be available in NCBI Short Read Archive with accession number SRR1122446 as soon as it is released. Alternatively, the data can be obtained directly from the authors.</p>
</sec><sec id="s2f">
<title>Functional annotation cluster and pathway analysis</title>
<p>DAVID [<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/home.jsp" xlink:type="simple">http://david.abcc.ncifcrf.gov/home.jsp</ext-link>] functional annotation cluster analysis was performed on the list of up-regulated and down-regulated genes with a fold change of ≥4. Only those terms that reported a <italic>p</italic>-value of ≤0.05 and count number ≥5 genes were selected for analysis. The Gene Ontology (GO) terms of cellular component, molecular function and biological process in DAVID were employed to categorize enriched biological themes in up- and down-regulated gene lists. Pathway mapping was performed using the KEGG Automatic Annotation Server (KAAS) <xref ref-type="bibr" rid="pone.0092447-Moriya1">[32]</xref>. The nucleotide sequences of up- and down-regulated genes were uploaded to the KAAS web server as an input using single-directional best hit (SBH) method to assign orthologs. KAAS offers functional annotation of genes in a genome via a BLAST similarity searches against a manually curated set of ortholog groups in the KEGG GENES database. KAAS assigned a KEGG Orthology (KO) number to genes in the data sets, which were mapped to one of KEGG's reference pathways.</p>
</sec><sec id="s2g">
<title>Real time RT-PCR validation</title>
<p>One microgram of RNA in a reaction mixture with a total volume of 20 μl was primed with oligo (dT)<sub>20</sub> primers (Bioneer, Daejeon, Korea) and then reverse transcribed at 42°C for 50 min and 72°C for 15 min. Subsequently, 2 μl of cDNA product and 10 pmoles of each gene-specific primer were used for PCR, using a 7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA). A Power SYBRH Green PCR Master Mix (Applied Biosystems) was used as the fluorescence source. Primers were designed with the Primer 3 software (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu" xlink:type="simple">http://frodo.wi.mit.edu</ext-link>) using the sequence information listed at the National Center for Biotechnology Information. Detailed information describing the primer sequences is provided in <bold><xref ref-type="supplementary-material" rid="pone.0092447.s004">Table S1</xref></bold>.</p>
</sec><sec id="s2h">
<title>Immunocytochemistry</title>
<p>Cells grown in a covered glass-bottom dish were stained with Pax7 or MyoG antibody. Briefly, cells were rinsed with PBS (phosphate buffered saline), fixed in 4% formaldehyde, permeabilized by 0.2% TritonX-100, after which the signals were enhanced using an Image-iT FX signal enhancer (Invitrogen). The cells were then incubated with mouse primary Pax7 or MyoG antibody (1∶50, Santa Cruz Biotechnology, CA, USA) at 4°C in a humid environment overnight. Secondary antibody (Alexa Fluor 488 goat anti-mouse SFX kit; Molecular Probes, Eugene, OR, USA) was treated for 1 hr at room temperature followed by nuclear staining with 4′,6′-diamino-2-phenylindole (DAPI; Sigma-Aldrich, MO, USA). Pictures were taken using a fluorescent microscope equipped with a digital camera (Nikon, Tokyo, Japan).</p>
</sec><sec id="s2i">
<title>Western blot</title>
<p>Western blot was performed with the total protein isolated from cells. Briefly, cells washed with ice-cold PBS were lysed in RIPA lysis buffer containing protease inhibitor cocktail (Thermo Scientific, IL, USA). The protein was quantified by Bradford method using protein assay dye solution. Fifty microgram of protein was electrophoresed in 10% SDS-polyacrylamide gel after reducing at 90°C for 3 min with β-mercaptoethanol, and the protein was transferred to a PVDF membrane. Membrane was blocked and hybridized with MyoG (1∶1000) or β-actin antibody (1∶2000) (Santa Cruz Biotechnology) overnight at 4°C. Membrane washed in TBST was then incubated with horseradish peroxidase conjugated secondary antibody for an hour at room temperature. Finally, the membrane was developed using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).</p>
</sec><sec id="s2j">
<title>Giemsa staining</title>
<p>Cells were washed with PBS, fixed with PBS/methanol (v/v) for 2 min, and were incubated with 0.04% Giemsa G250 solution for 30 min. cells were rinsed with distilled water and pictures were taken using a light microscope equipped with a digital camera (Nikon).</p>
</sec><sec id="s2k">
<title>Statistical analysis</title>
<p>The normalized expression means were compared using Tukey's Studentized Range (HSD) to identify significant differences in gene expression. A nominal <italic>p</italic>-value of less than 0.05 was considered to be statistically significant. Real time RT-PCR data were analyzed by one-way ANOVA using PROC GLM in SAS package ver. 9.0 (SAS Institute, Cary, NC, USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title><italic>MyoG</italic> gene knock-down</title>
<p>MSCs isolated and cultured from bovine leg muscle were stained with Pax7 to determine the purity of cells. The isolated cells showed approximately 85% Pax7 positive cells (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s001">Figure S1</xref></bold>). The <italic>in vitro</italic> cultured bovine primary cells began to differentiate without serum deprivation. The initial myotubes became visible at Day 12, and the number of myotubes increased with time (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1A</bold></xref>). The expression level of <italic>MyoG</italic>, which is known to play a role in myogenic differentiation <xref ref-type="bibr" rid="pone.0092447-Wright2">[33]</xref>, was determined by real-time RT-PCR at different time points of primary bovine cells differentiation. <italic>MyoG</italic> was expressed throughout differentiation; however, there was a steep increase in its expression level at Day 12, which gradually increased until Day 18 (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1B</bold></xref>). Similarly, Western blot analysis revealed MyoG protein expression on Day 10 and Day 16 with higher levels occurring on Day 16 (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1C</bold></xref>). This expression profile of <italic>MyoG</italic> during differentiation is in accordance with those of previous studies <xref ref-type="bibr" rid="pone.0092447-Delgado1">[34]</xref>, <xref ref-type="bibr" rid="pone.0092447-Janot2">[35]</xref>. Moreover, the cells were authenticated to be in the state of myotube formation by inspecting the nuclear expression of MyoG protein at two different time points (Day 10 and Day 16) during cell differentiation. MyoG protein expression was observed at Day 10 and 16. Day 16 showed higher MyoG nuclear expression as compared with Day 10 proliferating cells (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1D</bold></xref>). To identify the genes differentially expressed as a consequence of <italic>MyoG</italic> knock-down, MSCs were transduced with shRNA specific for <italic>MyoG</italic>. RNA analysis following transduction revealed the specific decline of mRNA for shRNA induced MyoG<sub>kd</sub> as compared to its wild type counterpart (MyoG<sub>wd</sub>) (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1E</bold></xref>). Similarly, MyoG<sub>kd</sub> was confirmed at the protein level by Western blot analysis (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1F</bold></xref>). shRNA transduction against <italic>MyoG</italic> prohibited the nuclear expression of MyoG protein and the development of myotubes (<xref ref-type="fig" rid="pone-0092447-g001"><bold>Figure 1G and 1H</bold></xref>).</p>
<fig id="pone-0092447-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.g001</object-id><label>Figure 1</label><caption>
<title>Myogenesis is associated with increased <italic>MyoG</italic> expression.</title>
<p><bold>A</bold>) MSCs proliferation and differentiation in DMEM/10% FBS media. Myotube formation was observed from day 12, reaching a maximum at day 16. <bold>B</bold>) <italic>MyoG</italic> expression from RNA extracted and analyzed by real time RT-PCR. <italic>MyoG</italic> expression gradually increased with time. <bold>C</bold>) MyoG protein expression at Day 10 and Day 16 was determined by Western blot analysis and the protein intensity was measured by using Image J program. MyoG protein in Day 16 cells was significantly higher than in Day 10 cells. <bold>D</bold>) Immunocytochemistry analysis of Day 10 and Day 16 cells stained with MyoG antibody. Day 16 showed higher MyoG nuclear expression as compared with Day 10 proliferating cells. <bold>E)&amp; F)</bold> <italic>MyoG</italic> mRNA and protein expression of MSCs transfected with MyoG shRNA. <italic>MyoG</italic> expression was decreased in both RNA and protein level in MyoG<sub>kd</sub> cells relative to MyoG<sub>wd</sub> cells. <bold>G</bold>) Immunostaining of MyoG<sub>wd</sub> or MyoG<sub>kd</sub> cells with MyoG antibody. A significant decrease in nuclear MyoG protein expression was observed in MyoG<sub>kd</sub> cells. <bold>H</bold>) Giemsa staining performed in MyoG<sub>wd</sub> and MyoG<sub>kd</sub> cells. Myotube formation was decreased in MyoG<sub>kd</sub> cells relative to MyoG<sub>wd</sub> cells. Day 10 and MyoG<sub>wd</sub> represents control, respectively (mean ±S.D., n = 3). <italic>p</italic>-value indicates the statistical significance of the data and different letters (a and b) in graph show significant differences among groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s3b">
<title>Expression of myogenic marker genes</title>
<p>To confirm that primary bovine cells were undergoing differentiation, we verified the expression of <italic>myosin regulatory light chain 2</italic> (<italic>MYL2</italic>) and <italic>myosin heavy chain 3</italic> (<italic>MYH3</italic>), which have previously been shown to be expressed during myogenesis. Both <italic>MYL2</italic> and <italic>MYH3</italic>, which are marker genes <xref ref-type="bibr" rid="pone.0092447-Lee1">[24]</xref>, exhibited a gradual increase in expression rates during myogenesis, whereas <italic>cyclin A2</italic> (<italic>CCNA2</italic>), which is involved in the cell cycle <xref ref-type="bibr" rid="pone.0092447-Henglein1">[36]</xref>, showed moderate and decreased expression levels (<xref ref-type="fig" rid="pone-0092447-g002"><bold>Figure 2A</bold></xref>). The opposite trend was observed for <italic>MYL2</italic> and <italic>MYH3</italic>, with decreased mRNA expression, while the expression of <italic>CCNA2</italic> was significantly elevated as a result of MyoG<sub>kd</sub> (<xref ref-type="fig" rid="pone-0092447-g002"><bold>Figure 2B</bold></xref>). These results are in agreement with those of our previous study <xref ref-type="bibr" rid="pone.0092447-Lee2">[37]</xref>, <xref ref-type="bibr" rid="pone.0092447-Lee3">[38]</xref>, as well as those of other investigations of mouse and human skeletal muscle differentiation <xref ref-type="bibr" rid="pone.0092447-Moran1">[4]</xref>, <xref ref-type="bibr" rid="pone.0092447-Sterrenburg1">[39]</xref>.</p>
<fig id="pone-0092447-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.g002</object-id><label>Figure 2</label><caption>
<title>Effect of MyoG<sub>kd</sub> on <italic>MYL2</italic>, <italic>MYH3</italic> and <italic>CCNA2</italic> genes.</title>
<p><bold>A</bold>) Time course study of mRNA expression of <italic>MYL2</italic>, <italic>MYH3</italic> and <italic>CCNA2</italic> during MSCs differentiation. Cells cultured in differentiation media showed gradual increase in <italic>MYL2</italic> and <italic>MYH3</italic> expression until Day 18, but transient increase of <italic>CCNA2</italic> at day 12 decreased at later stage of myogenesis. <bold>B</bold>) Evaluation of <italic>MYL2</italic>, <italic>MYH3</italic>, and <italic>CCNA2</italic> gene expression by real time RT-PCR in MyoG<sub>kd</sub> cells. Decreased <italic>MYL2</italic> and <italic>MYH3</italic> gene expression and increased <italic>CCNA2</italic> expression was observed in MyoG<sub>kd</sub> cells relative to MyoG<sub>kd</sub> cells. Day 10 and MyoG<sub>wd</sub> represents control, respectively (mean ±S.D., n = 3). <italic>p</italic>-value indicates the statistical significance of the data and different letters (a, b and c) in graph show significant differences among groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.g002" position="float" xlink:type="simple"/></fig></sec><sec id="s3c">
<title>High-throughput sequencing</title>
<p>High-throughput RNA-Seq was applied to investigate the gene expression profiles of MyoG<sub>wd</sub> and MyoG<sub>kd</sub> samples. The total numbers of RNA-Seq reads (101 base pairs in length) generated in this study were about 42 million for MyoG<sub>wd</sub> and 46 million for MyoG<sub>kd</sub>. About 63.73% and 61.66% of the MyoG<sub>wd</sub> and MyoG<sub>kd</sub> reads, with at least one reported alignment, were mapped to the reference genome (<xref ref-type="table" rid="pone-0092447-t001"><bold>Table 1</bold></xref>). Post-run quality analysis of the RNA-Seq data was carried out using the FASTQC [<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/" xlink:type="simple">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>] tool in Galaxy <xref ref-type="bibr" rid="pone.0092447-Giardine1">[25]</xref>, <xref ref-type="bibr" rid="pone.0092447-Blankenberg1">[26]</xref>, <xref ref-type="bibr" rid="pone.0092447-Goecks1">[27]</xref>. The per base sequence quality report is one of the most useful FASTQC reports, which helps in deciding whether sequence trimming is required before alignment. <xref ref-type="fig" rid="pone-0092447-g003"><bold>Figure 3A–D</bold></xref> summarizes the range of quality standards across all bases at every point in the FastQ file. For each position a boxwhisker type plot is drawn. In general, the quality of calls will degrade as the run advances, therefore, it is prevalent to see base calls falling into the orange area towards the end of a read. The quality scores across all bases were determined by the Sanger/Illumina 1.9 encoding method. These figures represent good quality calls scattered across the green background of the plots. A warning will be pointed out if the lower quartile for any base is less than 10, or if the median for any base is less than 25, whereas a failure will be issued if the lower quartile for any base is less than 5 or if the median for any base is less than 20.</p>
<fig id="pone-0092447-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.g003</object-id><label>Figure 3</label><caption>
<title>Per base sequence quality of MyoG<sub>wd</sub> and MyoG<sub>kd</sub>.</title>
<p>Quality scores of <bold>A) &amp; B)</bold> MyoG<sub>wd</sub>, and <bold>C) &amp; D)</bold> MyoG<sub>kd</sub>. The y-axis on the graph shows the quality scores with higher scores indicating better base calls. The background of the graph separates the y axis into high-quality calls (green), calls of reasonable quality (orange), and calls of poor quality (red). In each of these findings, the red line is the median value, the yellow box corresponds to the inter-quartile range (25–75%), the upper and lower whiskers represent the 10% and 90% points, respectively, and the blue line signifies the mean quality.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.g003" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0092447-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.t001</object-id><label>Table 1</label><caption>
<title>Number of single replicate RNA-Seq reads across MyoG<sub>wd</sub> and MyoG<sub>kd</sub> samples.</title>
</caption><alternatives><graphic id="pone-0092447-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Sample</td>
<td align="left" rowspan="1" colspan="1">Total read pairs<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">Processed reads<sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">Mapped reads<sup>c</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>MyoG<sub>wd</sub></bold></td>
<td align="left" rowspan="1" colspan="1">42,936,654</td>
<td align="left" rowspan="1" colspan="1">42,910,546</td>
<td align="left" rowspan="1" colspan="1">27,346,293 (63.73%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>MyoG<sub>kd</sub></bold></td>
<td align="left" rowspan="1" colspan="1">46,349,131</td>
<td align="left" rowspan="1" colspan="1">46,324,224</td>
<td align="left" rowspan="1" colspan="1">28,565,046 (61.66%)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>Foot note: a. Total read count b. Reads used in TopHat process c. Reads with at least one reported alignment.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d">
<title>Differentially expressed genes</title>
<p>Following mapping of the sequencing reads to the reference genome with TopHat <xref ref-type="bibr" rid="pone.0092447-Trapnell1">[28]</xref>, transcripts were assembled and their relative expression levels were computed with Cufflinks <xref ref-type="bibr" rid="pone.0092447-Trapnell2">[31]</xref> in FPKM. A total of 13,703 unique genes were detected and further filtered to remove possible noise from the data by excluding the genes with FPKM values equal to zero from the analysis. As a result, 9,337 and 12,835 genes were identified from MyoG<sub>wd</sub> and MyoG<sub>kd</sub> samples respectively, which shared 8,469 genes in common (<xref ref-type="table" rid="pone-0092447-t002"><bold>Table 2</bold></xref>). These 8,469 genes were then used to calculate the fold change, which was defined as the ratio of MyoG<sub>kd</sub> FPKM to MyoG<sub>wd</sub> FPKM. In this study, the total fold change of ≥4 was considered to classify the differentially expressed genes. Based on this definition, there are 230 up-regulated and 224 down-regulated genes in MyoG<sub>kd</sub> over the MyoG<sub>wd</sub> sample (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s005">Table S2</xref></bold>). We found that <italic>SAP30-like</italic> (<italic>SAP30L</italic>) was the most up-regulated gene in MyoG<sub>kd</sub> by 126-fold (log<sub>2</sub> fold change  = 6.98) and encodes a protein that plays a potential role in the histone deacetylase complex, similar to Sin3 associated protein 30 (SAP30) <xref ref-type="bibr" rid="pone.0092447-Lindfors1">[40]</xref>.</p>
<table-wrap id="pone-0092447-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.t002</object-id><label>Table 2</label><caption>
<title>Gene expression summary.</title>
</caption><alternatives><graphic id="pone-0092447-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Sample</td>
<td align="left" rowspan="1" colspan="1">MyoG<sub>wd</sub></td>
<td align="left" rowspan="1" colspan="1">MyoG<sub>kd</sub></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Total No. of genes</td>
<td align="left" rowspan="1" colspan="1">9,337</td>
<td align="left" rowspan="1" colspan="1">12,835</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Common in MyoG<sub>wd</sub>/MyoG<sub>kd</sub></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">8,469</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Up-regulated (≥4 fold)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">230</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Down-regulated (≥4 fold)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">224</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap>
<p><italic>SAP30</italic> was identified as one of the transcriptional regulators in C2C12 differentiation <xref ref-type="bibr" rid="pone.0092447-Rajan1">[41]</xref>. <italic>Ribosomal protein L23a</italic> (<italic>RPL23A</italic>), <italic>zinc finger protein 322A (ZNF322A)</italic>, <italic>solute carrier family 16 member 3</italic> (<italic>SLC16A3</italic>), <italic>tubulin, alpha 1c</italic> (<italic>TUBA1C</italic>), <italic>sulfotransferase family, cytosolic, 2B, member 1</italic> (<italic>SULT2B1</italic>), <italic>metallothionein 2A</italic> (<italic>MT2A</italic>), <italic>matrix metallopeptidase 9</italic> (<italic>MMP9</italic>), <italic>secreted frizzled-related protein 1</italic> (<italic>SFRP1</italic>) and <italic>myelin protein</italic> (<italic>MBP</italic>) were among the ten most up-regulated genes in MyoG<sub>kd</sub>. <italic>MT2A</italic>, a member of cysteine-rich and metal binding intracellular proteins <xref ref-type="bibr" rid="pone.0092447-Jin1">[42]</xref> that has been linked with cell proliferation <xref ref-type="bibr" rid="pone.0092447-Cherian1">[43]</xref>, was up-regulated by 17.77-fold. In addition to <italic>MT2A</italic>, the other two metallothioneins (<italic>MT1A</italic> and <italic>MT1E</italic>) present in the list of differentially expressed genes also showed up-regulation by more than four-fold. Another group of highly up-regulated genes belonged to a class of matrix <italic>metalloproteinases</italic> (<italic>MMPs</italic>). A total of 13 <italic>MMPs</italic> were identified in this study, almost all of which showed a high fold change. <italic>MMP1</italic>, <italic>MMP3</italic>, <italic>MMP9</italic> (one of the ten most up-regulated genes) and <italic>MMP13</italic> were up-regulated by more than four-fold, whereas <italic>MMP2</italic> and <italic>MMP12</italic> were up-regulated by more than two-fold. Similarly, <italic>MMP15</italic>, <italic>MMP19</italic>, <italic>MMP20</italic>, <italic>MMP23B</italic> and <italic>MMP27</italic> were up-regulated by more than one-fold. Only one of the <italic>MMPs</italic>, <italic>MMP16</italic>, was down-regulated. Increased expression of <italic>MMPs</italic> (particularly <italic>MMP9</italic>) in skeletal muscles is well known <xref ref-type="bibr" rid="pone.0092447-Dahiya1">[44]</xref>; therefore, our analysis is consistent with the results of previous studies. These <italic>MMPs</italic> enable release of the active <italic>hepatocyte growth factor</italic> (<italic>HGF</italic>), which stimulates proliferation while inhibiting differentiation, from extracellular matrix (ECM) <xref ref-type="bibr" rid="pone.0092447-Bentzinger1">[45]</xref>. The other genes that showed a greater than four-fold increase in expression include a transcription repressor, <italic>musculin</italic> also known as <italic>MyoR</italic> (myogenic repressor), which is known to block myogenesis and the activation of E-box dependent muscle genes <xref ref-type="bibr" rid="pone.0092447-Lu1">[46]</xref>.</p>
<p><italic>Protein lyl-1</italic> (<italic>LYL1</italic>), also known as <italic>lymphoblastic leukemia-derived sequence 1</italic>, was found to be one of the ten most down-regulated genes. <italic>LYL1</italic> consists of a basic helix-loop-helix (bHLH) domain (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s002">Figure S2</xref></bold>), which is similar to genes involved in mammalian myogenesis (<italic>MyoD</italic>, <italic>MyoG</italic>, <italic>Myf5</italic>, and <italic>herculin</italic>) <xref ref-type="bibr" rid="pone.0092447-Miyamoto1">[47]</xref>. <italic>LYL1</italic> is an essential gene required for the development of adult hematopoietic stem cells <xref ref-type="bibr" rid="pone.0092447-Souroullas1">[48]</xref>. The other ten most down-regulated genes include <italic>sodium channel protein type 1 subunit alpha</italic> (<italic>SCN1A</italic>), <italic>ribosomal protein S15a</italic> (<italic>RPS15A</italic>), <italic>syncoilin</italic> (<italic>SYNC</italic>), <italic>tubulin alpha-1D</italic> (<italic>TUBA1D</italic>), <italic>family with sequence similarity 65, member B</italic> (<italic>FAM65B</italic>), <italic>agouti-signaling protein</italic> (<italic>ASIP</italic>), <italic>tocopherol (alpha) transfer protein-like</italic> (<italic>TTPAL</italic>), <italic>ryanodine receptor 1</italic> (<italic>RYR1</italic>), and an uncharacterized protein (LOC100847946). <italic>Myocyte enhancer factor 2C</italic> (<italic>MEF2C</italic>) is a member of the <italic>MEF2</italic> family of transcription factors that was down-regulated by two-fold, whereas another member of the <italic>MEF2</italic> family, <italic>MEF2A</italic>, was down-regulated by about 1.5-fold. <italic>MEF2</italic> transcription factors play prominent roles in skeletal muscle differentiation <xref ref-type="bibr" rid="pone.0092447-Molkentin2">[49]</xref>, <xref ref-type="bibr" rid="pone.0092447-BrandSaberi1">[50]</xref>, and four <italic>MEF2</italic> isoforms (<italic>MEF2A</italic>, <italic>MEF2B</italic>, <italic>MEF2C</italic> and <italic>MEF2D</italic>) have been identified to date <xref ref-type="bibr" rid="pone.0092447-Brand1">[51]</xref>, <xref ref-type="bibr" rid="pone.0092447-Black1">[52]</xref>. It is well known that increased expression of <italic>MEF2C</italic> occurs during myoblast differentiation <xref ref-type="bibr" rid="pone.0092447-McDermott1">[53]</xref>, <xref ref-type="bibr" rid="pone.0092447-Martin1">[54]</xref>, <xref ref-type="bibr" rid="pone.0092447-AlKhalili1">[55]</xref>. In comparison with the up-regulated genes, down-regulated genes consisted of those that play crucial roles in phosphate metabolic processes. There is a significant amount of evidence that the processes related to phosphorylation and dephosphorylation of tyrosine are important regulatory components during the progression of myogenesis <xref ref-type="bibr" rid="pone.0092447-Lin1">[56]</xref>, <xref ref-type="bibr" rid="pone.0092447-Quach1">[57]</xref>, <xref ref-type="bibr" rid="pone.0092447-Kaliman1">[58]</xref>, <xref ref-type="bibr" rid="pone.0092447-Fornaro1">[59]</xref>.</p>
</sec><sec id="s3e">
<title>Functional annotation cluster and pathway analysis</title>
<p>To categorize biological processes that are overrepresented in MyoG<sub>wd</sub> and MyoG<sub>kd</sub> cells, we classified all known differentially expressed genes (fold change ≥4) using the Functional Annotation Cluster (FAC) tool available in the Database for Annotation, Visualization and Integrated Discovery (DAVID) [<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/home.jsp" xlink:type="simple">http://david.abcc.ncifcrf.gov/home.jsp</ext-link>]. DAVID FAC analysis of 230 up-regulated genes (fold change ≥4) generated a total of 65 functional clusters using default parameters. The GO terms “Biological Process”, “Cellular Component” and “Molecular Function” were used for annotations. Genes with a variety of GO terms from the resulting functional clusters having statistically significant <italic>p</italic>-values are listed in <xref ref-type="table" rid="pone-0092447-t003"><bold>Table 3A</bold></xref>. Similarly, the GO functional annotation chart reported 50 chart records that were further filtered to 22 records by selecting only those terms having <italic>p</italic>-values ≤0.05 and number of genes in each term ≥5 (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s006">Table S3A</xref></bold>). From these tables, it can be seen that the GO terms are enriched in genes with functions necessary for actively proliferating cells such as cell division, DNA replication, cell cycle function and mitosis. The other major processes that exhibit higher levels of gene expression as a consequence of MyoG<sub>kd</sub> include GO terms related to organelle lumen, nucleoplasm and cytosol. These data suggest that the proliferating processes are the major processes up-regulated by MyoG<sub>kd</sub>, and that their overrepresentation may be due to the de-differentiation of muscle cells. The down-regulation of <italic>MyoG</italic> in terminally differentiated mouse C2C12 myotubes was recently shown to stimulate cellular cleavage into mononucleated cells and promote cell cycle re-entry <xref ref-type="bibr" rid="pone.0092447-Mastroyiannopoulos1">[11]</xref>. This phenomenon of dedifferentiation of myotubes into proliferating mononucleated cells is well known <xref ref-type="bibr" rid="pone.0092447-McGann1">[60]</xref>, <xref ref-type="bibr" rid="pone.0092447-Odelberg1">[61]</xref>, <xref ref-type="bibr" rid="pone.0092447-Jung1">[62]</xref>.</p>
<table-wrap id="pone-0092447-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.t003</object-id><label>Table 3</label><caption>
<title>Significantly enriched gene ontology terms detected by FAC in A) up-regulated genes, and B) down-regulated genes.</title>
</caption><alternatives><graphic id="pone-0092447-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">S. No.</td>
<td align="left" rowspan="1" colspan="1">GO Term (Fold enrichment)</td>
<td align="left" rowspan="1" colspan="1">No. of Genes</td>
<td align="left" rowspan="1" colspan="1">P-Value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>A) Up-regulated</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>1.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0005654∼nucleoplasm (1.92)</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">0.0047</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>2.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0031981∼nuclear lumen (1.54)</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">0.0189</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>3.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0031974∼membrane-enclosed lumen (1.45)</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">0.0203</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>4.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0043233∼organelle lumen (1.44)</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">0.0254</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>5.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0070013∼intracellular organelle lumen (1.43)</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">0.0306</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>6.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0005615∼extracellular space (1.91)</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">0.0157</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>7.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0044421∼extracellular region part (1.68)</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">0.0227</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>8.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0004222∼metalloendopeptidase activity (3.85)</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.0404</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>9.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0043933∼macromolecular complex subunit organization (1.76)</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.037</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>10.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0000280∼nuclear division (2.84)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0225</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>11.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0007067∼Mitosis (2.84)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0225</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>12.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0000087∼M phase of mitotic cell cycle (2.79)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0245</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>13.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0048285∼organelle fission (2.73)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0272</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>14.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0051301∼cell division (2.39)</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.0349</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>15.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0007049∼cell cycle (1.71)</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">0.0384</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>16.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0005819∼Spindle (3.14)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0418</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>17.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0005875∼microtubule associated complex (3.77)</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.043</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>18.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0000278∼mitotic cell cycle (2.11)</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.0469</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>19.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0007346∼regulation of mitotic cell cycle (3.09)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0447</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>B) Down-regulated</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>1.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0004721∼phosphoprotein phosphatase activity (3.51)</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">0.0146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>2.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0006470∼protein amino acid dephosphorylation (3.72)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0224</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>3.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0016311∼dephosphorylation (3.21)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0387</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>4.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0043292∼contractile fiber (4.06)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0159</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>5.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0030017∼sarcomere (4.18)</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.0312</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>6.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0030016∼myofibril (3.69)</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.046</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>7.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0044449∼contractile fiber part (3.63)</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.0486</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>8.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0000904∼cell morphogenesis involved in differentiation (3.38)</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.0028</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>9.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0000902∼cell morphogenesis (2.55)</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.0111</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>10.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0032989∼cellular component morphogenesis (2.29)</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.022</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>11.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0031175∼neuron projection development (2.58)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0355</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>12.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0048666∼neuron development (2.19)</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.0529</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>13.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0016049∼cell growth (8.11)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0008</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>14.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0040007∼growth (3.61)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0067</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>15.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0008361∼regulation of cell size (3.20)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.0126</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>16.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0032535∼regulation of cellular component size (2.74)</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.017</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>17.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0031090∼organelle membrane (1.64)</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">0.0239</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>18.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0031966∼mitochondrial membrane (2.08)</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.0506</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>19.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0005874∼microtubule (2.69)</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.0186</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>20.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0005856∼cytoskeleton (1.48)</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">0.0445</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>21.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0006796∼ phosphate metabolic process (1.70)</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">0.0251</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>22.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0006793∼phosphorus metabolic process (1.70)</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">0.0251</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>23.</bold></td>
<td align="left" rowspan="1" colspan="1">GO:0030424∼axon (3.09)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.0443</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap>
<p>Functional analysis of 224 down-regulated genes resulted in 69 clusters, and the statistically significant (<italic>p</italic>-value ≤0.05) GO terms having at least five members in each enriched term are listed in <xref ref-type="table" rid="pone-0092447-t003"><bold>Table 3B</bold></xref>. The GO functional annotation chart reported 59 records, 21 of which were selected on the basis of a <italic>p</italic>-value ≤0.05 and number of genes in each term ≥5 (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s006">Table S3B</xref></bold>). The processes that were significantly down-regulated by MyoG<sub>kd</sub> as shown by functional analysis include phosphate metabolic processes, dephosphorylation, phosphoprotein phosphatase activity and protein amino acid dephosphorylation. Additionally, processes related to the cell shape such as cytoskeleton and cell morphogenesis (<xref ref-type="table" rid="pone-0092447-t003"><bold>Table 3B</bold></xref><bold> &amp; <xref ref-type="supplementary-material" rid="pone.0092447.s006">Table S3B</xref></bold>) were also down-regulated. In addition to DAVID FAC, by performing KEGG pathway analysis of 455 up- and down-regulated genes, we were able to assign 281 unique KEGG orthologs to these differentially expressed query genes. The majority of the differentially expressed genes were found to be associated with important biological processes, many being classified in signaling pathway or being involved in adhesion and cytoskeleton related functions (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s003">Figure S3A</xref>–<xref ref-type="supplementary-material" rid="pone.0092447.s003">S3E</xref></bold>).</p>
</sec><sec id="s3f">
<title>Glycogenes expression</title>
<p>To further explore the role of glycogenes in myogenesis, all 230 up- and 224 down-regulated genes were manually verified in the UniProt database <xref ref-type="bibr" rid="pone.0092447-Bairoch1">[63]</xref> to check whether they represent a glycogene or not. If a gene encoded a protein and represented glycosyltransferases, glycosidases, lectins, sulfotransferases or proteins involved in carbohydrate metabolism or transport <xref ref-type="bibr" rid="pone.0092447-Janot1">[5]</xref>, it was labeled as a glycogene. In this way, we identified 59 (∼25%) up- and 52 (∼23%) down-regulated glycogenes out of 230 and 224 differentially expressed gene sets. Some of the glycogenes that demonstrated four-fold increase in expression rates included <italic>SCNN1A</italic>, <italic>SFRP1</italic> and <italic>transmembrane protein 217</italic> (<italic>TMEM217</italic>). Additionally, various glycogenes such as <italic>matrix metalloproteinases</italic> (<italic>MMP1</italic>, <italic>MMP13</italic>, <italic>MMP3</italic> and <italic>MMP9</italic>) and genes belonging to the solute carrier family (<italic>SLC26A8</italic>, <italic>SLC2A6</italic>, <italic>SLC37A2</italic> and <italic>SLC46A3</italic>) exhibited more than four-fold up-regulation as a consequence of MyoG<sub>kd</sub>. Similarly, the glycogenes that showed four-fold decrease included <italic>SCN1A</italic>, <italic>ASIP</italic> and <italic>protein wnt-11</italic> (<italic>WNT11</italic>). The list of top ten up- and down-regulated genes consisted of at least two glycogenes.</p>
</sec><sec id="s3g">
<title>Validation of RNA sequencing data</title>
<p>To validate the RNA-Seq results, we performed real-time RT-PCR to determine the expression levels of marker genes (<italic>Myf5</italic>, <italic>MyoD</italic>, <italic>MyoG</italic>, <italic>MYL2</italic> and <italic>MYH3</italic>) involved in myogenesis and then compared their expression with RNA-Seq data in MyoG<sub>kd</sub> samples. The RT-PCR results were well correlated with the RNA-Seq expression data for the five marker genes investigated (<xref ref-type="fig" rid="pone-0092447-g004"><bold>Figure 4A</bold></xref>). Specifically, RT-PCR analysis of <italic>Myf5</italic>, <italic>MyoD</italic>, <italic>MyoG</italic>, <italic>MYL2</italic> and <italic>MYH3</italic> mRNA levels revealed fold changes of 0.72, 1.32, 0.42, 0.35 and 0.67, respectively (approximately &gt;2-fold decrease) in MyoG<sub>kd</sub> relative to MyoG<sub>wd</sub> cells. These results compliment favorably well with our RNA-Seq data showing fold changes of 0.8 (<italic>Myf5</italic>), 2.23 (<italic>MyoD</italic>), 0.49 (<italic>MyoG</italic>), 0.33 (<italic>MYL2</italic>) and 0.49 (<italic>MYH3</italic>), which also corresponded to a two-fold decline in the expression of these marker genes. As an additional confirmation of the expression data, ten genes were randomly selected for RT-PCR analysis, five of them representing the ten most-up and down-regulated genes. The results revealed that the fold-change profiles measured by RNA-Seq and RT-PCR were concordant for all ten genes. However, RT-PCR analysis showed statistically significant expression of only eight out of these additional ten genes (<xref ref-type="fig" rid="pone-0092447-g004"><bold>Figure 4B–K</bold></xref>). Among the RNA-Seq data, SAP30, <italic>MT2A, sorting nexin 9</italic> (<italic>SNX9</italic>), <italic>transthyretin</italic> (<italic>TTR</italic>), <italic>and matrix gla protein</italic> (<italic>MGP</italic>), were up-regulated 126.47-fold, 17.77-fold, 5.75-fold, 2.5-fold, and 2.1-fold, respectively. RT-PCR also indicated an approximately four-fold increase in expression for SAP30, MT2A whereas TTR and MGP showed about 2 fold increase in their expression. However, RT-PCR results of SNX9 exhibited about 1.4-fold increase. Similarly, <italic>SCN1A</italic>, <italic>SYNC</italic>, <italic>RYR1, plexin 1</italic> (<italic>PLXNC1</italic>), and <italic>copine III</italic> (<italic>CPNE3</italic>) were down-regulated by 0.01-fold, 0.02-fold, 0.08-fold, 0.13-fold, and 0.17-fold (&gt;4-fold), respectively. However, the RT-PCR data indicated an approximately two-fold decrease in their expression levels.</p>
<fig id="pone-0092447-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.g004</object-id><label>Figure 4</label><caption>
<title>Real time RT-PCR validation of muscle specific and differentially expressed genes on MyoG<sub>kd</sub>.</title>
<p><bold>A</bold>) Fold changes of <italic>Myf5</italic>, <italic>MyoD</italic>, <italic>MyoG</italic>, <italic>MYL2</italic>, and <italic>MYH3</italic> genes determined by RNA sequencing were compared with real-time RT PCR results. <bold>B–K</bold>) RT-PCR validation of mRNA expression for five randomly selected genes confirmed the increased expression of <italic>MT2A SAP30</italic>, <italic>TTR</italic>, <italic>MGP</italic>, and <italic>SNX9</italic> genes and decreased expression of <italic>SCN1A</italic>, <italic>SYNC</italic>, <italic>RYR1, PLXNC1</italic>, and <italic>CPNE3</italic> genes by MyoG<sub>kd</sub>. MyoG<sub>wd</sub> represents control, respectively (mean ±S.D., n = 3). <italic>p</italic>-value indicates the statistical significance of the data and different letters (a and b) in graph show significant differences among groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.g004" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>The current study offers the first thorough insight into the transcriptome analysis of primary bovine MSCs with MYOG<sub>kd</sub> using RNA-Seq technology. The number of total reads that map to the reference genome met the high quality criterion of the RNA-seq technology <xref ref-type="bibr" rid="pone.0092447-Mortazavi1">[64]</xref>. The most practical justification for reads not mapping uniquely to the reference genome could be due to the sequencing errors or polymorphisms, reads that come from repetitive sequences, and reads from exon-exon junctions <xref ref-type="bibr" rid="pone.0092447-Marioni1">[65]</xref>.</p>
<p>Several genome wide high-throughput studies have been applied to investigate the functional role of various genes during myogenesis <xref ref-type="bibr" rid="pone.0092447-Moran1">[4]</xref>, <xref ref-type="bibr" rid="pone.0092447-Sterrenburg1">[39]</xref>, <xref ref-type="bibr" rid="pone.0092447-Shen1">[66]</xref>, <xref ref-type="bibr" rid="pone.0092447-Tomczak1">[67]</xref>. Recently, a microarray based study of <italic>MyoG</italic> has shown its role in mediating cell cycle exit in the absence of <italic>p38α</italic> and recognized an important function of <italic>p38α</italic> in cell fusion through the up-regulation of <italic>CD53</italic> <xref ref-type="bibr" rid="pone.0092447-Liu1">[68]</xref>. Another DNA microarray based study identified approximately 193 additional transcriptional regulators with varying expression levels during myogenesis <xref ref-type="bibr" rid="pone.0092447-Rajan1">[41]</xref>. DNA microarray has also been used to observe global changes in C2C12 cells transcriptome stimulated by exogenous <italic>myostatin</italic> (also known as <italic>GDF8</italic>) treatment, as well as to identify a network of genes involved in the inhibitory effects on differentiation <xref ref-type="bibr" rid="pone.0092447-Wicik1">[69]</xref>. In addition to microarray based studies, the RNA-Seq technique has been applied using C2C12 mouse myoblast cell lines to detect 13,692 known transcripts and 3,724 unannotated transcripts <xref ref-type="bibr" rid="pone.0092447-Langmead1">[29]</xref>. These sequencing or array-based methods have been shown to improve our understanding of myogenesis by revealing a broad range of target genes of myogenic transcription factors, novel myogenic factors and the characteristics of myoblasts and myotubes, which are difficult to identify by traditional approaches.</p>
<p>However, almost all of the aforementioned studies have used C2C12 mouse cell lines. We recently used primary bovine cells of high purity <xref ref-type="bibr" rid="pone.0092447-Lee4">[70]</xref> to identify genes differentially expressed during differentiation and transdifferentiation of MSCs and differentiation of preadipocytes <xref ref-type="bibr" rid="pone.0092447-Lee2">[37]</xref>, <xref ref-type="bibr" rid="pone.0092447-Lee4">[70]</xref>. MSCs are stem cells that reside between the sarcolemma and the basal lamina of adult skeletal muscle <xref ref-type="bibr" rid="pone.0092447-Asakura1">[71]</xref>. Since the serum derived from bovine species is an essential component of the <italic>in vitro</italic> cell culture system, there would be a great advantage of using bovine primary MSCs that closely mimic the <italic>in vivo</italic> situation during myogenesis <xref ref-type="bibr" rid="pone.0092447-Lee5">[72]</xref>. Indeed, such studies might enable enhancement of muscle fiber characteristics, leading to improved meat quality. <italic>MyoG</italic> is specifically responsible for muscle fiber characteristics and closely associated with meat quality by affecting muscle development <xref ref-type="bibr" rid="pone.0092447-Wang1">[73]</xref>, <xref ref-type="bibr" rid="pone.0092447-Kim1">[74]</xref>.</p>
<sec id="s4a">
<title>Key processes altered during MyoG<sub>kd</sub></title>
<sec id="s4a1">
<title>Genes involved in cell cycle regulation and DNA replication</title>
<p>MyoG<sub>kd</sub> caused up-regulation of a large number of genes involved in functions related to cell proliferation, such as DNA replication, the cell cycle and mitosis (<xref ref-type="table" rid="pone-0092447-t003"><bold>Table 3A</bold></xref><bold> &amp; <xref ref-type="supplementary-material" rid="pone.0092447.s006">Table S3A</xref></bold>). <xref ref-type="fig" rid="pone-0092447-g002"><bold>Figure 2B</bold></xref> verified the computational results showing that <italic>CCNA2</italic> expression increased by more than ten-fold in response to MyoG<sub>kd</sub> based on real time RT-PCR. Cell cycle related genes in these groups consist of several cell division homologue genes including <italic>cell division cycle 45</italic> (<italic>CDC45</italic>), <italic>cell division cycle 20</italic> (<italic>CDC20</italic>) and <italic>cell division cycle 6</italic> (<italic>CDC6</italic>), each showing more than a four-fold change. Promoter studies in quiescent myoblasts have shown that <italic>MyoD</italic> activates the expression of <italic>CDC6</italic> and <italic>minichromosome maintenance complex component 2</italic> (<italic>MCM2</italic>) genes, which prepare chromatin for DNA replication and as a result progression of the cell through the S-phase. Additionally, several other key cell division cycle-associated proteins including <italic>cell division cycle associated 2</italic> (<italic>CDCA2</italic>), <italic>cell division cycle associated 3</italic> (<italic>CDCA3</italic>), <italic>cell division cycle associated 7</italic> (<italic>CDCA7</italic>) and <italic>cell division cycle 8</italic> (<italic>CDC8</italic>) were up-regulated in response to MyoG<sub>kd</sub>. <italic>MyoG</italic> plays a critical role in mediating terminal differentiation through cell cycle exit, and the activation of several cell cycle genes as a consequence of <italic>MyoG</italic> down-regulation is well known <xref ref-type="bibr" rid="pone.0092447-Liu1">[68]</xref>. Among the transcription factors, <italic>E2F transcription factor 1</italic> (<italic>E2F1</italic>), which is known to play important roles in regulating cell proliferation <xref ref-type="bibr" rid="pone.0092447-Wang2">[75]</xref>, was up-regulated by about seven-fold. Previous studies have demonstrated that the expression of <italic>MyoG</italic> is strongly correlated with miRNA (miR-20a) expression, which in turn controls cell cycle exit by targeting E2F transcription factors <xref ref-type="bibr" rid="pone.0092447-Liu1">[68]</xref>, <xref ref-type="bibr" rid="pone.0092447-ODonnell1">[76]</xref>, <xref ref-type="bibr" rid="pone.0092447-Sylvestre1">[77]</xref>, <xref ref-type="bibr" rid="pone.0092447-Nagel1">[78]</xref>. Two high mobility group box genes (<italic>HMG20B</italic> and <italic>HMGA1</italic>) that play a role in the regulation of DNA-dependent processes (transcription, replication, and DNA repair) involved in altering the conformation of chromatin also belong to this group of up-regulated biological processes <xref ref-type="bibr" rid="pone.0092447-Thomas1">[79]</xref>. Moreover, expression of MCM proteins (putative replicative helicase) such as <italic>MCM5</italic> is necessary for DNA replication <xref ref-type="bibr" rid="pone.0092447-Tye1">[80]</xref>, <xref ref-type="bibr" rid="pone.0092447-Forsburg1">[81]</xref> and essential for DNA replication fork progression <xref ref-type="bibr" rid="pone.0092447-Labib1">[82]</xref>, <xref ref-type="bibr" rid="pone.0092447-Pacek1">[83]</xref>.</p>
</sec><sec id="s4a2">
<title>Processes related to organelle lumen, nucleoplasm and cytosol</title>
<p>DAVID functional analysis identified 59 unique genes up-regulated by more than four-fold representing the GO terms organelle lumen, nucleoplasm and cytosol (<xref ref-type="table" rid="pone-0092447-t003"><bold>Table 3A</bold></xref><bold> and <xref ref-type="supplementary-material" rid="pone.0092447.s006">Table S3A</xref></bold>). These genes included transcription factor <italic>E2F1</italic>, <italic>endoplasmic reticulum resident protein 44</italic> (<italic>ERP44</italic>), <italic>gamma-enolase</italic> (<italic>ENO2</italic>) and <italic>vascular endothelial growth factor-D</italic> (<italic>VEGF-D</italic>), which are involved in a wide variety of biological processes. The proteins belonging to the E2F family of transcription factors play a significant role in controlling cell proliferation. For example, <italic>E2F1</italic> is considered the key target of pRB and is regulated by pRB throughout cell proliferation <xref ref-type="bibr" rid="pone.0092447-Sahin1">[84]</xref>. <italic>ERP44</italic>, a <italic>thioredoxin</italic> (<italic>TRX</italic>) family protein known to be involved in oxidative protein folding, directly regulates or inhibits the channel activity of <italic>inositol 1,4,5-trisphosphate receptors</italic> (<italic>IP<sub>3</sub>Rs</italic>). <italic>ERP44</italic> exclusively interacts with the L3V domain of <italic>IP<sub>3</sub>R1</italic>, and this binding is dependent on pH, Ca<sup>2+</sup> concentration, and redox state <xref ref-type="bibr" rid="pone.0092447-Higo1">[85]</xref>. <italic>ENO2</italic>, a membrane protein, has been reported as a marker of <italic>neuro-muscular junctions</italic> (<italic>NMJs</italic>), whose expression decreases considerably during the initial stages of human embryonic muscle tissue development <xref ref-type="bibr" rid="pone.0092447-Merkulova1">[86]</xref>. <italic>VEGF-D</italic> interacts with, and induces dimerization and tyrosine autophosphorylation of its endothelial cell-specific receptor, <italic>VEGFR-2</italic>, which stimulates endothelial sprouting, proliferation, and survival, as well as vascular permeability. Similarly, binding of VEGF-D with VEGFR-3 stimulates related processes in lymphatic endothelial cells <xref ref-type="bibr" rid="pone.0092447-Achen1">[87]</xref>, <xref ref-type="bibr" rid="pone.0092447-Shibuya1">[88]</xref>, <xref ref-type="bibr" rid="pone.0092447-Tammela1">[89]</xref>, <xref ref-type="bibr" rid="pone.0092447-Leppnen1">[90]</xref>.</p>
</sec><sec id="s4a3">
<title>Phosphorus metabolic process</title>
<p>FAC analysis identified phosphorous metabolic processes as an important biological process in MyoG<sub>kd</sub> cells (<xref ref-type="table" rid="pone-0092447-t003"><bold>Table 3B</bold></xref><bold> &amp; <xref ref-type="supplementary-material" rid="pone.0092447.s006">Table S3B</xref></bold>). Both the FAC and function annotation chart analysis detected about 21 unique genes that exhibited ≥4-fold decrease in their expression rates and were involved in phosphorous related processes. These genes included various phosphatases and kinases such as <italic>receptor-type tyrosine-protein phosphatase beta</italic> (<italic>PTPRB</italic>), <italic>serine/threonine-protein phosphatases PP1-beta catalytic subunit</italic> (<italic>PPP1CB</italic>), <italic>serine/threonine-protein kinase 40</italic> (<italic>STK40</italic>) and <italic>cyclin-dependent kinase 13</italic> (<italic>CDK13</italic>). One of the main mechanisms by which the signaling cascades control various stages of myogenesis is through protein kinases that direct cell behavior via the reversible process of phosphorylation <xref ref-type="bibr" rid="pone.0092447-Knight1">[91]</xref>. Extensive studies have revealed that protein tyrosine phosphatases play a vital role in regulation of skeletal muscle myogenesis <xref ref-type="bibr" rid="pone.0092447-Fornaro1">[59]</xref>, <xref ref-type="bibr" rid="pone.0092447-Hinard1">[92]</xref>, <xref ref-type="bibr" rid="pone.0092447-Lu2">[93]</xref>, while dephosphorylation of tyrosine residues is required for cell cycle exit during myogenesis <xref ref-type="bibr" rid="pone.0092447-DeOliveira1">[94]</xref>. The KEGG pathway analysis identified various pathways that lead to down-regulation of various protein phosphatases during at least one step of their representative pathway, such as the PI3K-Akt signaling pathway, MAPK signaling pathway, focal adhesion, TGF-beta signaling pathway and hippo signaling pathway (<xref ref-type="fig" rid="pone-0092447-g005"><bold>Figure 5</bold></xref>). One of the down-regulated genes is protein phosphatase 1, catalytic subunit, beta isozyme (<italic>PPP1CB</italic>), which encodes a serine/threonine-protein phosphatase PP1-beta catalytic subunit, an important enzyme responsible for protein phosphorylation and regulation of many physiological processes <xref ref-type="bibr" rid="pone.0092447-Huang1">[95]</xref>. Pathway analysis also illustrated that <italic>PPP1CB</italic> is involved in many important pathways related to myogenesis such as focal adhesion, the Hippo signaling pathway and regulation of the actin cytoskeleton (<bold><xref ref-type="supplementary-material" rid="pone.0092447.s003">Figure S3A</xref>–E</bold>).</p>
<fig id="pone-0092447-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092447.g005</object-id><label>Figure 5</label><caption>
<title>KEGG pathway map analysis of differentially expressed genes (≥4-fold change).</title>
<p>Among the various different pathways reported by KEGG analysis, two representative pathways <bold>A</bold>) PI3K-AKT and <bold>B</bold>) MAPK are shown. For each rectangular shape, red and green borders indicate up-regulated and down-regulated genes, while the yellow star indicates a role of phosphoprotein. Each KEGG pathway analysis figure depicts the role or involvement of a specific gene or a family of related genes at a particular location in the pathway. For instance, the FGF gene in KEGG MAPK pathway map represents the other FGF members (such as FGF10, FGF11, FGF12, etc) as well that may or may not be affected. Here, FGF represents all the members of fibroblast growth factor family. For FGF family members, the gene that exhibited &gt;4 fold increase includes FGF11 whereas FGF10, FGF16, and FGF18 showed &gt;1 fold increase in their expression rates. Conversely, the other FGF members that showed &lt;4 fold decreased expression include FGF12 and FGF14. Similarly, FGFR represents the other members (FGFR1, FGFR2, etc) of this family of receptors as well. In case of FGFR family, FGFR2 showed &gt;4 fold decrease in its expression, and FGFR4 exhibited &gt;1 fold decrease in its expression rate. However, FGFR1 and FGFR3 showed about 1 fold increase in their expressions.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092447.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s4a4">
<title>Cytoskeleton and cell morphogenesis</title>
<p>DAVID FAC indicated that the GO terms cytoskeleton and cell morphogenesis involved in differentiation were down-regulated in response to MyoG<sub>kd</sub>. The analyses identified about 39 unique genes involved in these processes that showed ≥4-fold reduction in their expression rates. The location of most of the genes in this category is either cytoplasm or labeled as secreted in the Uniprot database. The genes under these biological processes are involved in a broad range of functions such as signaling pathways, transport, differentiation, etc. Some of these genes include <italic>disabled homolog 2</italic> (<italic>DAB2</italic>), <italic>microtubule-associated protein 2</italic> (<italic>MAP2</italic>), <italic>synaptopodin-2 or myopodin</italic> (<italic>SYNPO2</italic>), and <italic>moesin</italic> (<italic>MSN</italic>). Among these genes, <italic>DAB2</italic> (expressed in various tissues), which is detected at an early myogenic differentiation state <xref ref-type="bibr" rid="pone.0092447-Tomczak1">[67]</xref>, has lost or reduced expression in hyperproliferative cells <xref ref-type="bibr" rid="pone.0092447-Fazili1">[96]</xref>. Another gene in this group that is significantly down-regulated is a member of the tissue inhibitors of matrix metalloproteinases (<italic>TIMP</italic>) family, <italic>TIMP3</italic>, or <italic>metalloproteinase inhibitor 3</italic>. <italic>TIMP3</italic> complexes with <italic>MMPs</italic> and is the only <italic>TIMP</italic> capable of inhibiting membrane bound <italic>MMP</italic>, transmembrane <italic>MMP</italic> and sheddases such as TNF-α converting enzyme (TACE), which is also known as disintegrin and metalloproteinase (ADAM-17) <xref ref-type="bibr" rid="pone.0092447-Amour1">[97]</xref>, <xref ref-type="bibr" rid="pone.0092447-Shen2">[98]</xref>. Conversely, all <italic>MMPs</italic> detected in this study were highly up-regulated. Pathway analysis also revealed that one of the ERM proteins known to regulate cross-linking of the plasma membrane and actin cytoskeleton, <italic>MSN</italic>, was down-regulated <xref ref-type="bibr" rid="pone.0092447-Fehon1">[99]</xref>, <xref ref-type="bibr" rid="pone.0092447-Tsukita1">[100]</xref>, <xref ref-type="bibr" rid="pone.0092447-Henning1">[101]</xref>.</p>
</sec></sec><sec id="s4b">
<title>Role of glycogene expression in myogenesis</title>
<p>Skeletal muscle development consists of a well controlled and regulated progression of various cellular processes, including cell proliferation, migration, and differentiation <xref ref-type="bibr" rid="pone.0092447-Brandan1">[102]</xref>. Until recently, the role of glycoproteins in myogenesis did not receive a great deal of attention from the scientific community <xref ref-type="bibr" rid="pone.0092447-Janot1">[5]</xref>, <xref ref-type="bibr" rid="pone.0092447-Brandan1">[102]</xref>. However, many independent studies have recently focused on the numerous roles of glycoconjugates during myogenesis <xref ref-type="bibr" rid="pone.0092447-Brandan1">[102]</xref>. The results of these studies have indicated that the expression of <italic>MyoG</italic> is partly regulated by the reduced glycosylation-dependent recruitment of <italic>Mef2D</italic> to <italic>MyoG</italic> promoter, suggesting negative regulatory mechanisms of skeletal muscle development by O-GlcNAc glycosylation <xref ref-type="bibr" rid="pone.0092447-Ogawa1">[103]</xref>.</p>
<p>Different processes related to the formation and maintenance of skeletal muscles are characterized by the expression of a wide variety of molecules that strongly alter biological events, such as muscle development, differentiation and regeneration. Among the different types of macromolecules participating in myogenesis, interest in glycoproteins has been gaining remarkable attention in recent years; however, there are still several unanswered questions regarding their roles during skeletal muscle development <xref ref-type="bibr" rid="pone.0092447-Brandan1">[102]</xref>. Similar to other eukaryotic cells, the plasma membrane and ECM of myoblasts are rich in glycoproteins and glycolipids <xref ref-type="bibr" rid="pone.0092447-Janot1">[5]</xref>. Inhibition of some ECM proteoglycans (<italic>syndecans</italic>) has shown to stop the progression of myoblast proliferation and fusion, regardless of the expression of MRFs <xref ref-type="bibr" rid="pone.0092447-Osses1">[104]</xref>, <xref ref-type="bibr" rid="pone.0092447-Cornelison1">[105]</xref>. Similarly, interrupting N-glycan synthesis affects myoblast fusion <xref ref-type="bibr" rid="pone.0092447-Metzler1">[106]</xref>. Glycolipids also play key roles in cell differentiation and muscle development <xref ref-type="bibr" rid="pone.0092447-Fukumoto1">[107]</xref>, <xref ref-type="bibr" rid="pone.0092447-Yanagisawa1">[108]</xref>.</p>
</sec><sec id="s4c">
<title>Role of channels in myogenesis</title>
<p>The initial phases of myogenesis are marked by the development of excitability and contractile properties by skeletal muscle cells <xref ref-type="bibr" rid="pone.0092447-Ugarte1">[109]</xref>. Voltage dependent sodium channels comprise one of the key types of proteins that play a pivotal role in propagating action potential in nerves and muscle <xref ref-type="bibr" rid="pone.0092447-Yu1">[110]</xref>, <xref ref-type="bibr" rid="pone.0092447-Hodgkin1">[111]</xref>, <xref ref-type="bibr" rid="pone.0092447-MartnezMrmol1">[112]</xref>. <italic>SCN1A</italic> consists of four homologous domains <xref ref-type="bibr" rid="pone.0092447-Barela1">[113]</xref>, and its activity is regulated by the interaction with <italic>fibroblast growth factor 13</italic> (<italic>FGF13</italic>) <xref ref-type="bibr" rid="pone.0092447-Wang3">[114]</xref>. Many mutational studies have recognized a variety of tainted channel properties that include changes in the voltage dependence of activation and inactivation, speedy recuperation from inactivation, improved constant current and loss of channel function <xref ref-type="bibr" rid="pone.0092447-Barela1">[113]</xref>. Similarly, <italic>RYR1</italic>, a calcium channel that plays an important role in excitation–contraction coupling in skeletal muscles, has shown increased expression levels during the early stages of myogenesis along with <italic>dihydropyridine receptors</italic> (<italic>DHPRs</italic>) <xref ref-type="bibr" rid="pone.0092447-Vega1">[115]</xref>. <italic>SYNC</italic>, which belongs to the <italic>intermediate filament</italic> (<italic>IF</italic>) family of proteins <xref ref-type="bibr" rid="pone.0092447-Newey1">[116]</xref>, is greatly expressed in skeletal and cardiac muscles and may play an important role in maintaining contractile properties <xref ref-type="bibr" rid="pone.0092447-McCullagh1">[117]</xref>. <italic>SYNC</italic> is known to interact with another member of the IF family, <italic>desmin</italic>, and may play a significant role in protecting muscle cells from mechanical stress <xref ref-type="bibr" rid="pone.0092447-Capetanaki1">[118]</xref>, <xref ref-type="bibr" rid="pone.0092447-Costa1">[119]</xref> in a fashion similar to that of other members of the IF family <xref ref-type="bibr" rid="pone.0092447-Parry1">[120]</xref>.</p>
<p>Together, these data offer extensive and deeper insight into the transcriptional regulation of myogenesis by <italic>MyoG</italic> and provide a rich scope for designing future experiments to elucidate the pathways involved in skeletal muscle differentiation. Furthermore, to improve muscle growth as well as quality and quantity of meat, it is essential to recognize how <italic>MyoG</italic> influences the differentiation of MSCs.</p>
</sec></sec><sec id="s5">
<title>Conclusion</title>
<p>In summary, our transcriptome analysis of primary bovine cells using RNA-Seq offers important insight into the transcriptional regulation of gene expression in down-regulated <italic>MyoG</italic> muscle cells. In addition to the identification of new genes in skeletal muscle development, our bioinformatics analysis suggested a role of phosphorous metabolic processes, proteins with channeling function, and the involvement of a significant number of glycogenes in myogenesis. Further investigation of the genes identified in this study will facilitate our understanding and help explain the mechanism responsible for increasing skeletal muscle mass.</p>
</sec><sec id="s6">
<title>Supporting Information</title>
<supplementary-material id="pone.0092447.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0092447.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Pax7 expression in MSCs.</bold> Cellular localization of Pax7 on MSCs at Day 10 by immunocytochemistry. <bold>A</bold>) Cell picture <bold>B</bold>) DAPI-stained nuclei. <bold>C</bold>) Pax7 antibody stained cells.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0092447.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0092447.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Multiple sequence alignment of LYL1 and other bHLH genes.</bold> Multiple sequence alignment of LYL1 (UNIPROT ID: E1BAR3) protein and other bHLH proteins (MyoD, MyoG, Myf5, and herculin) which are involved in skeletal muscle development. The region in the box indicates high sequence similarity in the bHLH region of these muscle specific proteins.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0092447.s003" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pone.0092447.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Other muscle specific pathways affected by MYOG<sub>kd</sub>.</bold> <bold>A</bold>) WNT signaling pathway, <bold>B</bold>) Focal adhesion, <bold>C</bold>) TGF-beta signaling pathway, <bold>D</bold>) Hippo signaling pathway, E) PPAR signaling pathway.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pone.0092447.s004" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="info:doi/10.1371/journal.pone.0092447.s004" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>Primer information.</bold></p>
<p>(XLSX)</p>
</caption></supplementary-material><supplementary-material id="pone.0092447.s005" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="info:doi/10.1371/journal.pone.0092447.s005" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p><bold>List of up- and down-regulated genes.</bold> Each sheet contains up- and down-regulated genes separately that show at least 4 fold change in their expression.</p>
<p>(XLSX)</p>
</caption></supplementary-material><supplementary-material id="pone.0092447.s006" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="info:doi/10.1371/journal.pone.0092447.s006" position="float" xlink:type="simple"><label>Table S3</label><caption>
<p><bold>GO functional annotation chart.</bold> GO functional annotation chart records for <bold>A</bold>) up-regulated genes, and <bold>B</bold>) Down-regulated genes. Only those terms that have <italic>p</italic>-values ≤0.05 and number of genes in each term ≥5 are shown.</p>
<p>(XLSX)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>All research materials used in this study were provided by the Bovine Genome Resources Bank, Yeungnam University, Gyeongsan, Korea.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0092447-Olson1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Brennan</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Chakraborty</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Cserjesi</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Molecular control of myogenesis: antagonism between growth and differentiation</article-title>. <source>Mol Cell Biochem</source> <volume>104</volume>: <fpage>7</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Mohun1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mohun</surname><given-names>T</given-names></name> (<year>1992</year>) <article-title>Muscle differentiation</article-title>. <source>Curr Opin Cell Biol</source> <volume>4</volume>: <fpage>923</fpage>–<lpage>928</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Andrs1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andrés</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>K</given-names></name> (<year>1996</year>) <article-title>Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis</article-title>. <source>J Cell Biol</source> <volume>4</volume>: <fpage>657</fpage>–<lpage>66</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Moran1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moran</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Mounts</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>CP</given-names></name> (<year>2002</year>) <article-title>Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling</article-title>. <source>Physiol Genomics</source> <volume>10</volume>: <fpage>103</fpage>–<lpage>11</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Janot1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Janot</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Audfray</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Loriol</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Germot</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maftah</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates</article-title>. <source>BMC Genomics</source> <volume>10</volume>: <fpage>483</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Rudnicki1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rudnicki</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Jaenisch</surname><given-names>R</given-names></name> (<year>1995</year>) <article-title>The MyoD family of transcription factors and skeletal myogenesis</article-title>. <source>Bioessays</source> <volume>17</volume>: <fpage>203</fpage>–<lpage>209</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Naya1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naya</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>E</given-names></name> (<year>1999</year>) <article-title>MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation</article-title>. <source>Curr Opin Cell Biol</source> <volume>11</volume>: <fpage>683</fpage>–<lpage>688</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lassar1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lassar</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Kadesch</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Murre</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo</article-title>. <source>Cell</source> <volume>2</volume>: <fpage>305</fpage>–<lpage>15</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Murre1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murre</surname><given-names>C</given-names></name>, <name name-style="western"><surname>McCaw</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Vaessin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Caudy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jan</surname><given-names>LY</given-names></name>, <etal>et al</etal>. (<year>1989</year>) <article-title>Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence</article-title>. <source>Cell</source> <volume>3</volume>: <fpage>537</fpage>–<lpage>44</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Berkes1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berkes</surname><given-names>CA</given-names></name> (<year>2005</year>) <name name-style="western"><surname>Tapscott</surname><given-names>SJ</given-names></name> (<year>2005</year>) <article-title>MyoD and the transcriptional control of myogenesis</article-title>. <source>Semin Cell Dev Biol</source> <volume>16</volume>: <fpage>585</fpage>–<lpage>595</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Mastroyiannopoulos1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mastroyiannopoulos</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Nicolaou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Anayasa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Uney</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Phylactou</surname><given-names>LA</given-names></name> (<year>2012</year>) <article-title>Down-regulation of myogenin can reverse terminal muscle cell differentiation</article-title>. <source>PLOS ONE</source> <volume>7</volume>: <fpage>e29896</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Kitzmann1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kitzmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Carnac</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vandromme</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Primig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lamb</surname><given-names>NJ</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells</article-title>. <source>J Cell Biol</source> <volume>142</volume>: <fpage>1447</fpage>–<lpage>1459</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Molkentin1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molkentin</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name> (<year>1996</year>) <article-title>Defining the regulatory networks for muscle development</article-title>. <source>Curr Opin Genet Dev</source> <volume>6</volume>: <fpage>445</fpage>–<lpage>453</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Rhodes1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rhodes</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Konieczny</surname><given-names>SF</given-names></name> (<year>1989</year>) <article-title>Identification of MRF4: a new member of the muscle regulatory factor gene family</article-title>. <source>Genes Dev</source> <volume>3</volume>: <fpage>2050</fpage>–<lpage>2061</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Wright1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wright</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Sassoon</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>VK</given-names></name> (<year>1989</year>) <article-title>Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD</article-title>. <source>Cell</source> <volume>4</volume>: <fpage>607</fpage>–<lpage>17</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Singh1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singh</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dilworth</surname><given-names>FJ</given-names></name> (<year>2013</year>) <article-title>Differential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factors</article-title>. <source>FEBS J</source> <volume>280</volume>: <fpage>3991</fpage>–<lpage>4003</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Hasty1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hasty</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bradley</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Edmondson</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Venuti</surname><given-names>JM</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene</article-title>. <source>Nature</source> <volume>364</volume>: <fpage>501</fpage>–<lpage>506</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Nabeshima1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nabeshima</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hanaoka</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hayasaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Esumi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Myogenin gene disruption results in perinatal lethality because of severe muscle defect</article-title>. <source>Nature</source> <volume>364</volume>: <fpage>532</fpage>–<lpage>535</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Rawls1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rawls</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Rudnicki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>HH</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis</article-title>. <source>Dev Biol</source> <volume>172</volume>: <fpage>37</fpage>–<lpage>50</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Myer1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Myer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>WH</given-names></name> (<year>2001</year>) <article-title>MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells</article-title>. <source>Dev Biol</source> <volume>229</volume>: <fpage>340</fpage>–<lpage>350</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Rudnicki2"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rudnicki</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hinuma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jaenisch</surname><given-names>R</given-names></name> (<year>1992</year>) <article-title>Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development</article-title>. <source>Cell</source> <volume>3</volume>: <fpage>383</fpage>–<lpage>90</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Zhang1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Behringer</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name> (<year>1995</year>) <article-title>Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies</article-title>. <source>Genes Dev</source> <volume>11</volume>: <fpage>1388</fpage>–<lpage>1399</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Meadows1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meadows</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Flynn</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>WH</given-names></name> (<year>2008</year>) <article-title>Myogenin regulates a distinct genetic program in adult muscle stem cells</article-title>. <source>Dev Biol</source> <volume>322</volume>: <fpage>406</fpage>–<lpage>414</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lee1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Bajracharya</surname><given-names>Prati</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>YS</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Gene expression profiles during differentiation and transdifferentiation of bovine myogenic satellite cells</article-title>. <source>Genes &amp; Genomics</source> <volume>34</volume>: <fpage>133</fpage>–<lpage>148</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Giardine1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giardine</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Riemer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hardison</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Burhans</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Elnitski</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Galaxy: a platform for interactive large-scale genome analysis</article-title>. <source>Genome Res</source> <volume>15</volume>: <fpage>1451</fpage>–<lpage>1455</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Blankenberg1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blankenberg</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Von Kuster</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Coraor</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Manipulation of FASTQ data with Galaxy</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>1783</fpage>–<lpage>1785</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Goecks1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goecks</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nekrutenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Afgan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ananda</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences</article-title>. <source>Genome Biol</source> <volume>11</volume>: <fpage>R86</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Trapnell1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trapnell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pachter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Salzberg</surname><given-names>SL</given-names></name> (<year>2009</year>) <article-title>TopHat: discovering splice junctions with RNA-Seq</article-title>. <source>Bioinformatics</source> <volume>25</volume>: <fpage>1105</fpage>–<lpage>1111</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Langmead1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Langmead</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Trapnell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pop</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Salzberg</surname><given-names>SL</given-names></name> (<year>2010</year>) <article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>. <source>Genome Biol</source> <volume>10</volume>: <fpage>R25</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Altschul1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Altschul</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Gish</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Lipman</surname><given-names>DJ</given-names></name> (<year>1990</year>) <article-title>Basic local alignment search tool</article-title>. <source>J Mol Biol</source> <volume>215</volume>: <fpage>403</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Trapnell2"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trapnell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Pertea</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mortazavi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat Biotechnol</source> <volume>28</volume>: <fpage>511</fpage>–<lpage>515</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Moriya1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moriya</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Itoh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Okuda</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yoshizawa</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>KAAS: an automatic genome annotation and pathway reconstruction server</article-title>. <source>Nucleic Acids Res</source> <volume>35</volume>: <fpage>W182</fpage>–<lpage>185</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Wright2"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wright</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Sassoon</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>VK</given-names></name> (<year>1989</year>) <article-title>Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD</article-title>. <source>Cell</source> <volume>4</volume>: <fpage>607</fpage>–<lpage>17</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Delgado1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Delgado</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hatcher</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Dynamic gene expression during the onset of myoblast differentiation in vitro</article-title>. <source>Genomics</source> <volume>2</volume>: <fpage>109</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Janot2"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Janot</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Audfray</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Loriol</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Germot</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maftah</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates</article-title>. <source>BMC Genomics</source> <volume>10</volume>: <fpage>483</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Henglein1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Henglein</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chenivesse</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Eick</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bréchot</surname><given-names>C</given-names></name> (<year>1994</year>) <article-title>Structure and cell cycle-regulated transcription of the human cyclin A gene</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>91</volume>: <fpage>5490</fpage>–<lpage>4</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lee2"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Kamli</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Pokharel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>AR</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Depot-specific gene expression profiles during differentiation and transdifferentiation of bovine muscle satellite cells, and differentiation of preadipocytes</article-title>. <source>Genomics</source> <volume>100</volume>: <fpage>195</fpage>–<lpage>202</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lee3"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Kamli</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Pokharel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chun</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title><italic>Transthyretin</italic> Is a Key Regulator of Myoblast Differentiation</article-title>. <source>PLOS ONE</source> <volume>8</volume>: <fpage>e63627</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Sterrenburg1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sterrenburg</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>R</given-names></name>, <name name-style="western"><surname>'t Hoen</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>van Deutekom</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Boer</surname><given-names>JM</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Large-scale gene expression analysis of human skeletal myoblast differentiation</article-title>. <source>Neuromuscul Disord</source> <volume>14</volume>: <fpage>507</fpage>–<lpage>518</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lindfors1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindfors</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Viiri</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Niittynen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heinonen</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Mäki</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>TGF-beta induces the expression of SAP30L, a novel nuclear protein</article-title>. <source>BMC Genomics</source> <volume>1</volume>: <fpage>53</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Rajan1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rajan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chu Pham Dang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Djambazian</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zuzan</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation</article-title>. <source>Physiol Genomics</source> <volume>2</volume>: <fpage>183</fpage>–<lpage>197</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Jin1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>VT</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Dheen</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Metallothionein 2A expression is associated with cell proliferation in breast cancer</article-title>. <source>Carcinogenesis</source> <volume>23</volume>: <fpage>81</fpage>–<lpage>86</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Cherian1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cherian</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Apostolova</surname><given-names>MD</given-names></name> (<year>2000</year>) <article-title>Nuclear localization of metallothionein during cell proliferation and differentiation</article-title>. <source>Cell Mol Biol</source> <volume>46</volume>: <fpage>347</fpage>–<lpage>356</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Dahiya1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dahiya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bhatnagar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hindi</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Paul</surname><given-names>PK</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice</article-title>. <source>Hum Mol Genet</source> <volume>20</volume>: <fpage>4345</fpage>–<lpage>4359</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Bentzinger1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bentzinger</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>von Maltzahn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rudnicki</surname><given-names>MA</given-names></name> (<year>2010</year>) <article-title>Extrinsic regulation of satellite cell specification</article-title>. <source>Stem Cell Res Ther</source> <volume>1</volume>: <fpage>27</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lu1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name> (<year>1999</year>) <article-title>MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>2</volume>: <fpage>552</fpage>–<lpage>557</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Miyamoto1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miyamoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Naumovski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cleary</surname><given-names>ML</given-names></name> (<year>1996</year>) <article-title>Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells</article-title>. <source>Mol Cell Biol</source> <volume>16</volume>: <fpage>2394</fpage>–<lpage>2401</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Souroullas1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Souroullas</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Salmon</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sablitzky</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Curtis</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Goodell</surname><given-names>MA</given-names></name> (<year>2009</year>) <article-title>Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival</article-title>. <source>Cell Stem Cell</source> <volume>4</volume>: <fpage>180</fpage>–<lpage>186</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Molkentin2"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molkentin</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name> (<year>1995</year>) <article-title>Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins</article-title>. <source>Cell</source> <volume>83</volume>: <fpage>1125</fpage>–<lpage>1136</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-BrandSaberi1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brand-Saberi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Christ</surname><given-names>B</given-names></name> (<year>1999</year>) <article-title>Genetic and epigenetic control of muscle development in vertebrates</article-title>. <source>Cell Tissue Res</source> <volume>296</volume>: <fpage>199</fpage>–<lpage>212</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Brand1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brand</surname><given-names>NJ</given-names></name> (<year>1997</year>) <article-title>Myocyte enhancer factor 2 (MEF2)</article-title>. <source>Int J Biochem Cell Biol</source> <volume>12</volume>: <fpage>1467</fpage>–<lpage>1470</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Black1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Black</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>EN</given-names></name> (<year>1998</year>) <article-title>Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins</article-title>. <source>Annu Rev Cell Dev Biol</source> <volume>14</volume>: <fpage>167</fpage>–<lpage>196</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-McDermott1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McDermott</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Cardoso</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>Andres</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Leifer</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors</article-title>. <source>Mol Cell Biol</source> <volume>13</volume>: <fpage>2564</fpage>–<lpage>2577</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Martin1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Miano</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Hustad</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Copeland</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>NA</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing</article-title>. <source>Mol Cell Biol</source> <volume>14</volume>: <fpage>1647</fpage>–<lpage>1656</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-AlKhalili1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Khalili</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Krämer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wretenberg</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Krook</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation</article-title>. <source>Acta Physiol Scand</source>. <volume>180</volume>: <fpage>395</fpage>–<lpage>403</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lin1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Protein tyrosine phosphatase-like A regulates myoblast proliferation and differentiation through MyoG and the cell cycling signaling pathway</article-title>. <source>Mol Cell Biol</source> <volume>32</volume>: <fpage>297</fpage>–<lpage>308</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Quach1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quach</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Rando</surname><given-names>TA</given-names></name> (<year>2006</year>) <article-title>Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells</article-title>. <source>Dev Biol</source> <volume>293</volume>: <fpage>38</fpage>–<lpage>52</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Kaliman1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaliman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Viñals</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Testar</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Palacín</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zorzano</surname><given-names>A</given-names></name> (<year>1996</year>) <article-title>Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells</article-title>. <source>J Biol Chem</source> <volume>271</volume>: <fpage>19146</fpage>–<lpage>19151</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Fornaro1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fornaro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Burch</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>CE</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth</article-title>. <source>J Cell Biol</source> <volume>175</volume>: <fpage>87</fpage>–<lpage>97</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-McGann1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGann</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Odelberg</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Keating</surname><given-names>MT</given-names></name> (<year>2001</year>) <article-title>Mammalian myotube dedifferentiation induced by newt regeneration extract</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>98</volume>: <fpage>13699</fpage>–<lpage>13704</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Odelberg1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Odelberg</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kollhoff</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Keating</surname><given-names>MT</given-names></name> (<year>2000</year>) <article-title>Dedifferentiation of mammalian myotubes induced by msx1</article-title>. <source>Cell</source> <volume>103</volume>: <fpage>1099</fpage>–<lpage>1109</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Jung1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jung</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>DR</given-names></name> (<year>2011</year>) <article-title>Novel Chemically Defined Approach To Produce Multipotent Cells from Terminally Differentiated Tissue Syncytia</article-title>. <source>ACS Chem Biol</source> <volume>6</volume>: <fpage>553</fpage>–<lpage>562</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Bairoch1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bairoch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Apweiler</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Boeckmann</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>The Universal Protein Resource (UniProt)</article-title>. <source>Nucleic Acids Res</source> <volume>33</volume>: <fpage>D154</fpage>–<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Mortazavi1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mortazavi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>McCue</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schaeffer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wold</surname><given-names>B</given-names></name> (<year>2008</year>) <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>. <source>Nat Methods</source> <volume>5</volume>: <fpage>621</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Marioni1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marioni</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Mane</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Stephens</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gilad</surname><given-names>Y</given-names></name> (<year>2008</year>) <article-title>RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays</article-title>. <source>Genome Res</source> <volume>18</volume>: <fpage>1509</fpage>–<lpage>17</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Shen1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Collier</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Hlaing</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Delshad</surname><given-names>EH</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Genome-wide examination of myoblast cell cycle withdrawal during differentiation</article-title>. <source>Dev Dyn</source> <volume>1</volume>: <fpage>128</fpage>–<lpage>138</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Tomczak1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tomczak</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Marinescu</surname><given-names>VD</given-names></name>, <name name-style="western"><surname>Ramoni</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Sanoudou</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Montanaro</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Expression profiling and identification of novel genes involved in myogenic differentiation</article-title>. <source>FASEB J</source> <volume>18</volume>: <fpage>403</fpage>–<lpage>405</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Liu1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>QC</given-names></name>, <name name-style="western"><surname>Zha</surname><given-names>XH</given-names></name>, <name name-style="western"><surname>Faralli</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Louis-Jeune</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Comparative expression profiling identifies differential roles for Myogenin and p38α MAPK signaling in myogenesis</article-title>. <source>J Mol Cell Biol</source> <volume>4</volume>: <fpage>386</fpage>–<lpage>397</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Wicik1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wicik</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Sadkowski</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Jank</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Motyl</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>The transcriptomic signature of myostatin inhibitory influence on the differentiation of mouse C2C12 myoblasts</article-title>. <source>Pol J Vet Sci</source> <volume>4</volume>: <fpage>643</fpage>–<lpage>652</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lee4"><label>70</label>
<mixed-citation publication-type="other" xlink:type="simple">Lee EJ, Kamli MR, Pokharel S, Malik A, Tareq KMA, <etal>et al</etal>.. (2013) Expressed Sequence Tags for Bovine Muscle Satellite Cells, Myotube Formed-Cells and Adipocyte-Like Cells. PLOS ONE doi 10.1371/journal.pone.0079780.</mixed-citation>
</ref>
<ref id="pone.0092447-Asakura1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asakura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Komaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rudnicki</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation</article-title>. <source>Differentiation</source> <volume>68</volume>: <fpage>245</fpage>–<lpage>253</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lee5"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Bajracharya</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Effects of gender-specific adult bovine serum on myogenic satellite cell proliferation, differentiation and lipid accumulation</article-title>. <source>In Vitro Cell Dev Biol-Anim</source> <volume>47</volume>: <fpage>438</fpage>–<lpage>444</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Wang1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>XS</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>DU</surname><given-names>HR</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Correlation analysis of relationships between polymorphisms of high quality chicken myogenin gene and slaughter and meat quality traits</article-title>. <source>Front Agric China</source> <volume>2</volume>: <fpage>512</fpage>–<lpage>518</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Kim1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>KC</given-names></name> (<year>2009</year>) <article-title>Associations of the variation in the porcine myogenin gene with muscle fibre characteristics, lean meat production and meat quality traits</article-title>. <source>J Anim Breed Genet</source> <volume>126</volume>: <fpage>134</fpage>–<lpage>141</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Wang2"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rauscher</surname><given-names>FJ</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Cress</surname><given-names>WD</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name> (<year>2007</year>) <article-title>Regulation of E2F1 function by the nuclear corepressor KAP1</article-title>. <source>J Biol Chem</source> <volume>282</volume>: <fpage>29902</fpage>–<lpage>29909</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-ODonnell1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Donnell</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Wentzel</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Zeller</surname><given-names>KI</given-names></name>, <name name-style="western"><surname>Dang</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Mendell</surname><given-names>JT</given-names></name> (<year>2005</year>) <article-title>c-Myc-regulated microRNAs modulate E2F1 expression</article-title>. <source>Nature</source> <volume>435</volume>: <fpage>839</fpage>–<lpage>843</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Sylvestre1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sylvestre</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>De Guire</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Querido</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mukhopadhyay</surname><given-names>UK</given-names></name>, <name name-style="western"><surname>Bourdeau</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>An E2F/miR-20a autoregulatory feedback loop</article-title>. <source>J Biol Chem</source> <volume>282</volume>: <fpage>2135</fpage>–<lpage>2143</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Nagel1"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nagel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Venturini</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Przybylski</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Grabarczyk</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia</article-title>. <source>Leuk Lymphoma</source> <volume>50</volume>: <fpage>101</fpage>–<lpage>108</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Thomas1"><label>79</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname><given-names>JO</given-names></name> (<year>2001</year>) <article-title>HMG1 and 2: architectural DNA-binding proteins</article-title>. <source>Biochem Soc Trans</source> <volume>29</volume>: <fpage>395</fpage>–<lpage>401</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Tye1"><label>80</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tye</surname><given-names>BK</given-names></name> (<year>1999</year>) <article-title>MCM proteins in DNA replication</article-title>. <source>Annu Rev Biochem</source> <volume>68</volume>: <fpage>649</fpage>–<lpage>686</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Forsburg1"><label>81</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Forsburg</surname><given-names>SL</given-names></name> (<year>2004</year>) <article-title>Eukaryotic MCM proteins: beyond replication initiation</article-title>. <source>Microbiol Mol Biol Rev</source> <volume>68</volume>: <fpage>109</fpage>–<lpage>131</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Labib1"><label>82</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Labib</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kearsey</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Diffley</surname><given-names>JF</given-names></name> (<year>2001</year>) <article-title>MCM2-7 proteins are essential components of prereplicative complexes that accumulate cooperatively in the nucleus during G1-phase and are required to establish, but not maintain, the S-phase checkpoint</article-title>. <source>Mol Biol Cell</source> <volume>12</volume>: <fpage>3658</fpage>–<lpage>3667</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Pacek1"><label>83</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pacek</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>JC</given-names></name> (<year>2004</year>) <article-title>A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication</article-title>. <source>EMBO J</source> <volume>23</volume>: <fpage>3667</fpage>–<lpage>3676</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Sahin1"><label>84</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sahin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sladek</surname><given-names>TL</given-names></name> (<year>2010</year>) <article-title>E2F-1 has dual roles depending on the cell cycle</article-title>. <source>Int J Biol Sci</source> <volume>2</volume>: <fpage>116</fpage>–<lpage>128</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Higo1"><label>85</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Natsume</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Michikawa</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44</article-title>. <source>Cell</source> <volume>1</volume>: <fpage>85</fpage>–<lpage>98</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Merkulova1"><label>86</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Merkulova</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dehaupas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nevers</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Créminon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Alameddine</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Differential modulation of α, β and γ enolase isoforms in regenerating mouse skeletal muscle</article-title>. <source>European Journal of Biochemistry</source> <volume>267</volume>: <fpage>3735</fpage>–<lpage>3743</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Achen1"><label>87</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Achen</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Jeltsch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kukk</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>2</volume>: <fpage>548</fpage>–<lpage>553</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Shibuya1"><label>88</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shibuya</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Claesson-Welsh</surname><given-names>L</given-names></name> (<year>2006</year>) <article-title>Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis</article-title>. <source>Exp Cell Res</source> <volume>5</volume>: <fpage>549</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Tammela1"><label>89</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tammela</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Alitalo</surname><given-names>K</given-names></name> (<year>2010</year>) <article-title>Lymphangiogenesis: molecular mechanisms and future promise</article-title>. <source>Cell</source> <volume>4</volume>: <fpage>460</fpage>–<lpage>476</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Leppnen1"><label>90</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leppänen</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Jeltsch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Anisimov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tvorogov</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Aho</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Structural determinants of vascular endothelial growth factor-D receptor binding and specificity</article-title>. <source>Blood</source> <volume>117</volume>: <fpage>1507</fpage>–<lpage>1515</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Knight1"><label>91</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knight</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Kothary</surname><given-names>R</given-names></name> (<year>2011</year>) <article-title>The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis</article-title>. <source>Skelet Muscle</source> <volume>1</volume>: <fpage>29</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Hinard1"><label>92</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hinard</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Belin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Konig</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bader</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Bernheim</surname><given-names>L</given-names></name> (<year>2008</year>) <article-title>Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242</article-title>. <source>Development</source> <volume>135</volume>: <fpage>859</fpage>–<lpage>867</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Lu2"><label>93</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ennis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shinder</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sap</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>The differentiation of skeletal muscle cells involves a protein-tyrosine phosphatase-alpha-mediated C-Src signaling pathway</article-title>. <source>J Biol Chem</source> <volume>277</volume>: <fpage>46687</fpage>–<lpage>46695</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-DeOliveira1"><label>94</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Oliveira</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Marin</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Clemente</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Judice</surname><given-names>CC</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>SHP-2 regulates myogenesis by coupling to FAK signaling pathway</article-title>. <source>FEBS Lett</source> <volume>583</volume>: <fpage>2975</fpage>–<lpage>2981</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Huang1"><label>95</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>YZ</given-names></name>, <name name-style="western"><surname>Lei</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>DQ</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>CY</given-names></name> (<year>2006</year>) <article-title>Identification of a differentially expressed gene PPP1CB between porcine Longissimus dorsi of Meishan and Large WhitexMeishan hybrids</article-title>. <source>Acta Biochim Biophys Sin</source> <volume>38</volume>: <fpage>450</fpage>–<lpage>456</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Fazili1"><label>96</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fazili</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Mittelstaedt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>XX</given-names></name> (<year>1999</year>) <article-title>Disabled-2 inactivation is an early step in ovarian tumorigenicity</article-title>. <source>Oncogene</source> <volume>18</volume>: <fpage>3104</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Amour1"><label>97</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amour</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Slocombe</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Webster</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>CG</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3</article-title>. <source>FEBS Lett</source> <volume>435</volume>: <fpage>39</fpage>–<lpage>44</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Shen2"><label>98</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Winkler</surname><given-names>IG</given-names></name>, <name name-style="western"><surname>Barbier</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sims</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Hendy</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo</article-title>. <source>PLOS ONE</source> <volume>5</volume>: <fpage>e13086</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Fehon1"><label>99</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fehon</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>McClatchey</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Bretscher</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>Organizing the cell cortex: the role of ERM proteins</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>11</volume>: <fpage>276</fpage>–<lpage>87</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Tsukita1"><label>100</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsukita</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yonemura</surname><given-names>S</given-names></name> (<year>1999</year>) <article-title>Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins</article-title>. <source>J Biol Chem</source> <volume>274</volume>: <fpage>34507</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Henning1"><label>101</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Henning</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Stiedl</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Barry</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Morham</surname><given-names>SG</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>PDZD8 is a novel moesin-interacting cytoskeletal regulatory protein that suppresses infection by herpes simplex virus type 1</article-title>. <source>Virology</source> <volume>415</volume>: <fpage>114</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Brandan1"><label>102</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brandan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gutierrez</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title>Role of skeletal muscle proteoglycans during myogenesis</article-title>. <source>Matrix Biol</source> <volume>32</volume>: <fpage>289</fpage>–<lpage>297</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Ogawa1"><label>103</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ogawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sakakibara</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kamemura</surname><given-names>K</given-names></name> (<year>2013</year>) <article-title>Requirement of decreased O-GlcNAc glycosylation of Mef2D for its recruitment to the myogenin promoter</article-title>. <source>Biochem Biophys Res Commun</source>. <volume>433</volume>: <fpage>558</fpage>–<lpage>62</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Osses1"><label>104</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Osses</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Brandan</surname><given-names>E</given-names></name> (<year>2002</year>) <article-title>ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression</article-title>. <source>Am J Physiol Cell Physiol</source> <volume>282</volume>: <fpage>C383</fpage>–<lpage>394</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Cornelison1"><label>105</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cornelison</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Wilcox-Adelman</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Goetinck</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Rauvala</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rapraeger</surname><given-names>AC</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Essential and separable roles for Syndecan-3 and Syndecan-4 in skeletal muscle development and regeneration</article-title>. <source>Genes Dev</source> <volume>18</volume>: <fpage>2231</fpage>–<lpage>2236</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Metzler1"><label>106</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Metzler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gertz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sarkar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Schrader</surname><given-names>JW</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development</article-title>. <source>EMBO J</source> <volume>13</volume>: <fpage>2056</fpage>–<lpage>2065</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Fukumoto1"><label>107</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukumoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Iwamoto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sakai</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yuasa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fukumoto</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Current topics in pharmacological research on bone metabolism: osteoclast differentiation regulated by glycosphingolipids</article-title>. <source>J Pharmacol Sci</source> <volume>100</volume>: <fpage>195</fpage>–<lpage>200</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Yanagisawa1"><label>108</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yanagisawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>RK</given-names></name> (<year>2007</year>) <article-title>The expression and functions of glycoconjugates in neural stem cells</article-title>. <source>Glycobiology</source> <volume>17</volume>: <fpage>57R</fpage>–<lpage>74R</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Ugarte1"><label>109</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ugarte</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Brandan</surname><given-names>E</given-names></name> (<year>2006</year>) <article-title>Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability</article-title>. <source>J Biol Chem</source> <volume>27</volume>: <fpage>18473</fpage>–<lpage>18481</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Yu1"><label>110</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Catterall</surname><given-names>WA</given-names></name> (<year>2003</year>) <article-title>Overview of the voltage-gated sodium channel family</article-title>. <source>Genome Biol</source> <volume>4</volume>: <fpage>207</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Hodgkin1"><label>111</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hodgkin</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Huxley</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>B</given-names></name> (<year>1952</year>) <article-title>Measurement of current-voltage relations in the membrane of the giant axon of Loligo</article-title>. <source>J Physiol</source> <volume>116</volume>: <fpage>424</fpage>–<lpage>448</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-MartnezMrmol1"><label>112</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martínez-Mármol</surname><given-names>R</given-names></name>, <name name-style="western"><surname>David</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sanches</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Roura-Ferrer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Villalonga</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair</article-title>. <source>Cardiovasc Res</source> <volume>3</volume>: <fpage>430</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Barela1"><label>113</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barela</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Waddy</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Lickfett</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Anido</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability</article-title>. <source>J Neurosci</source> <volume>10</volume>: <fpage>2714</fpage>–<lpage>23</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Wang3"><label>114</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hoch</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Pitt</surname><given-names>GS</given-names></name> (<year>2011</year>) <article-title>Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels</article-title>. <source>J Biol Chem</source> <volume>27</volume>: <fpage>24253</fpage>–<lpage>63</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Vega1"><label>115</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vega</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Ramos-Mondragón</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Calderón-Rivera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zarain-Herzberg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Avila</surname><given-names>G</given-names></name> (<year>2011</year>) <article-title>Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1</article-title>. <source>J Physiol</source> <volume>19</volume>: <fpage>4649</fpage>–<lpage>4669</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Newey1"><label>116</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Newey</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Howman</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Ponting</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Nawrotzki</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle</article-title>. <source>J Biol Chem</source> <volume>9</volume>: <fpage>6645</fpage>–<lpage>6655</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-McCullagh1"><label>117</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCullagh</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kemp</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Giles</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse</article-title>. <source>Mamm Genome</source> <volume>5</volume>: <fpage>339</fpage>–<lpage>351</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Capetanaki1"><label>118</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Capetanaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bloch</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Kouloumenta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mavroidis</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Psarras</surname><given-names>S</given-names></name> (<year>2007</year>) <article-title>Muscle intermediate filaments and their links to membranes and membranous organelles</article-title>. <source>Exp Cell Res</source> <volume>10</volume>: <fpage>2063</fpage>–<lpage>2076</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Costa1"><label>119</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Costa</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Escaleira</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cataldo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mermelstein</surname><given-names>CS</given-names></name> (<year>2004</year>) <article-title>Desmin: molecular interactions and putative functions of the muscle intermediate filament protein</article-title>. <source>Braz J Med Biol Res</source> <volume>12</volume>: <fpage>1819</fpage>–<lpage>1830</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092447-Parry1"><label>120</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parry</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Strelkov</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Burkhard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Aebi</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Herrmann</surname><given-names>H</given-names></name> (<year>2007</year>) <article-title>Towards a molecular description of intermediate filament structure and assembly</article-title>. <source>Exp Cell Res</source> <volume>10</volume>: <fpage>2204</fpage>–<lpage>2216</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>